Obesity, other/unspecified

E4_OBESITYNAS

obesity: A disorder involving an excessive amount of body fat.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E66.8, E66.9 Hospital discharge: ICD-9 — 2780 Hospital discharge: ICD-8 — 27799 Cause of death: ICD-10 — E66.8, E66.9 Cause of death: ICD-9 — 2780 Cause of death: ICD-8 — 27799 2 out of 7 registries used, show all original rules.	17770
4. Check minimum number of events None	17770
5. Include endpoints None	17770
6. Filter based on genotype QC (FinnGen only)	17123

Control definitions (FinnGen only)

Control exclude: E4_OBESITY

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	E4_OBESITYNAS
CONTROL_EXCLUDE	E4_OBESITY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E66[8-9]
HD_ICD_9	2780
HD_ICD_8	27799
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E66[8-9]
COD_ICD_9	2780
COD_ICD_8	27799
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Obesity, other/unspecified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	101521	63163	37539
Only index persons	87711	55646	32065
Unadjusted period prevalence (%)
Whole population	1.52	1.81	1.05
Only index persons	1.75	2.05	1.22
Median age at first event (years)
Whole population	48.13	47.17	49.69
Only index persons	46.49	45.16	48.82

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	17123	12101	5022
Unadjusted period prevalence (%)	3.71	4.29	2.30
Median age at first event (years)	48.61	46.68	53.28

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
17770: Matched controls
177690

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

B01AB04

ATC

dalteparin; parenteral

3.4

319.1

1219

3761

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.6

315.4

2126

8962

XX_20

NOMESCO Finland

Bioimpedance measurement

57.3

313.6

176

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

3.8

310.0

997

2745

A10BB01

ATC

glibenclamide; oral

5.2

309.3

649

1281

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

6.7

307.7

1321

2100

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.1

307.7

3688

19377

C08CA01

ATC

amlodipine; oral

2.1

307.7

5990

34665

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.8

307.7

2401

9403

C09AA02

ATC

enalapril; systemic

2.5

307.7

3149

14226

M54.5

ICD-10 Finland

Low back pain

1.9

307.7

7109

46397

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

9.3

307.7

2373

2903

3051, ,

Kela drug reimbursment

12.4

307.7

532

440

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

4.9

307.7

749

1582

B03BA03

ATC

hydroxocobalamin; parenteral

4.2

307.7

1241

3136

A08AB01

ATC

orlistat; oral

36.8

307.7

463

129

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

4.8

307.7

808

1755

E66.8

ICD-10 Finland

Other obesity

612.0

307.7

12262

644

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.3

307.7

6240

33278

WX722

NOMESCO Finland

PEEP

5.4

307.7

1223

2407

A10BG03

ATC

pioglitazone; oral

6.3

307.7

635

1039

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.9

307.7

2692

10390

XG466

NOMESCO Finland

Sleep oxymetry

7.5

307.7

1073

1507

N06AB04

ATC

citalopram; systemic

2.1

307.7

4260

23143

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.8

307.7

6384

29383

E66.1

ICD-10 Finland

Drug-induced obesity

85.7

307.7

220

A10AB05

ATC

insulin aspart; parenteral

3.2

307.7

1675

5534

M04AA01

ATC

allopurinol; systemic

3.7

307.7

2516

7630

N02AJ06

ATC

codeine and paracetamol; systemic

1.9

307.7

8131

54678

Z3231

NOMESCO Finland

Registered nurse

2.2

307.7

5312

29403

N02AX02

ATC

tramadol; systemic, rectal

2.7

307.7

9196

50284

N06AX16

ATC

venlafaxine; oral

2.5

307.7

3533

16333

Z3226

NOMESCO Finland

Physiotherapist

2.5

307.7

3888

17705

162

Kela drug reimbursment

liraglutide

23.9

307.7

602

260

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

6.1

307.7

718

1211

SPAT1262

SPAT

Handing over of treatment supplies

3.0

307.7

3682

14155

A10BB12

ATC

glimepiride; oral

5.2

307.7

1461

2988

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

4396.5

307.7

2705

T82

ICPC

Obesity

15.1

307.7

2866

2233

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

10.1

307.7

2529

2864

N05AH04

ATC

quetiapine; oral

2.3

307.7

3921

19704

A10BJ05

ATC

dulaglutide; parenteral

9.3

307.7

757

849

A46

ICD-10 Finland

Erysipelas

3.4

307.7

3302

11099

A02BC02

ATC

pantoprazole; systemic

2.3

307.7

12762

92849

358

Kela drug reimbursment

liraglutide

24.6

307.7

252

104

A10BX07

ATC

[U] liraglutide

25.9

307.7

705

283

N06AX21

ATC

duloxetine; oral

2.5

307.7

2718

12186

A10AE04

ATC

insulin glargine; parenteral

3.9

307.7

2355

6700

RD210, ,

NOMESCO Finland

12.8

307.7

955

786

N06AB03

ATC

fluoxetine; oral

2.6

307.7

2891

12247

G47.3

ICD-10 Finland

Sleep apnoea

6.3

307.7

8010

20617

I10

ICD-10 Finland

Essential (primary) hypertension

3.0

307.7

10948

62172

205

Kela drug reimbursment

Chronic hypertension

3.0

307.7

4733

19095

B01AB05

ATC

enoxaparin; parenteral

2.8

307.7

6839

32507

N02BE01

ATC

paracetamol; systemic, rectal

3.0

307.7

16235

138747

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

3.8

307.7

3286

10122

E11

ICD-10 Finland

Type 2 diabetes mellitus

4.3

307.7

3981

11266

A10BJ01

ATC

exenatide; parenteral

15.6

307.7

443

291

C07AB07

ATC

bisoprolol; oral

2.1

307.7

7837

48942

L17

ICPC

Foot/toe symptom/complaint

2.0

307.7

5291

31547

OAB72

NOMESCO Finland

Weight control and weight loss guidance

26.8

307.7

558

215

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.9

307.7

2852

10903

27799

ICD-8 Finland

Obesity not specified as of endocrine origin

+∞

307.7

1030

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.7

307.7

2372

9651

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.4

307.7

4508

21667

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.1

307.7

3785

19979

T83

ICPC

Overweight

5.9

307.7

806

1416

J45.9

ICD-10 Finland

Asthma, unspecified

2.6

307.7

4265

18970

JDF01

NOMESCO Finland

Laparoscopic gastroplasty

1674.0

307.7

777

WX780

NOMESCO Finland

Remote monitoring CPAP

4.1

307.7

1148

2976

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

2.9

307.7

2278

8694

L28

ICPC

Limited function/disability (L)

2.4

307.7

2966

13925

A10BJ06

ATC

semaglutide; parenteral

9.1

307.7

2161

2661

A08AA02

ATC

fenfluramine; oral

12.1

307.7

343

288

E66.01

ICD-10 Finland

Obesity due to excess calories

60.5

307.7

8044

2397

QBJ30

NOMESCO Finland

Correction of abdominal apron

44.1

307.7

854

203

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

550.4

307.7

889

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

3.5

307.7

3464

11374

R60.0

ICD-10 Finland

Localized oedema

2.8

307.7

2475

9606

A10AC01

ATC

insulin (human); parenteral

3.9

307.7

1904

5308

103

Kela drug reimbursment

Diabetes, insulin-treated

4.5

307.7

6834

21609

A08AA10

ATC

sibutramine; oral

29.1

307.7

244

215

Kela drug reimbursment

Diabetes, non-insulin-treated

4.3

307.7

6311

20260

C03CA01

ATC

furosemide; systemic

3.8

307.7

5897

20677

160

Kela drug reimbursment

exenatide

24.0

307.7

1159

516

H02AB06

ATC

prednisolone; systemic

1.9

307.7

8712

59803

N03AX16

ATC

[U] pregabalin

2.2

307.7

4565

24543

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.7

307.7

2403

9867

T90

ICPC

Diabetes non-insulin dependent

4.1

307.7

5768

18614

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

307.7

8016

49313

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.5

307.7

3904

18297

A10BA02

ATC

metformin; oral

5.6

307.7

8063

22915

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.2

307.7

2650

9287

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

5.4

307.7

6528

17131

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.5

307.7

3195

14497

E66

ICD-10 Finland

Obesity

15.7

307.7

3905

3137

E66.9

ICD-10 Finland

Obesity, unspecified

221.8

307.7

6799

495

A08AA62

ATC

bupropion and naltrexone; systemic

15.5

307.7

309

203

E66.00

ICD-10 Finland

Metabolic syndrome

33.3

307.7

3812

1447

A10BJ02

ATC

liraglutide; parenteral

15.6

307.7

1663

1167

R4190

NOMESCO Finland

Nutritional therapy

9.6

307.7

1930

2237

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

3.2

307.7

2964

10407

R06.0

ICD-10 Finland

Dyspnoea

2.4

307.7

5174

26356

R5140

NOMESCO Finland

Monitoring the use of the aid

5.7

307.7

3771

7980

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.8

307.7

2630

10262

3055, ,

Kela drug reimbursment

16.5

307.7

292

180

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

+∞

307.7

854

J01FF01

ATC

clindamycin; systemic

2.2

307.7

5576

30566

C03AA03

ATC

hydrochlorothiazide; oral

3.1

307.7

1604

5550

I50.0

ICD-10 Finland

Congestive heart failure

3.9

307.7

1115

3005

S97

ICPC

Chronic ulcer skin

3.9

307.7

1246

3387

A10BH01

ATC

sitagliptin; oral

4.7

307.7

2405

5712

A10BK01

ATC

dapagliflozin; oral

4.0

307.7

1604

4326

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.0

307.7

8634

57573

E66.0

ICD-10 Finland

Obesity due to excess calories

570.9

307.7

765

R03AC02

ATC

salbutamol; inhalant

2.2

307.7

11181

77003

N06AX12

ATC

bupropion; oral

2.7

307.7

1925

7543

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.3

307.7

2935

14077

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

10.5

307.7

2763

3066

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

31.9

307.7

775

254

C03DA01

ATC

spironolactone; oral

3.3

307.7

2415

8035

M10.9

ICD-10 Finland

Gout, unspecified

3.6

307.7

1201

3524

I50.9

ICD-10 Finland

Heart failure, unspecified

3.4

307.7

2177

6930

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

6.3

307.7

708

1161

A10BK03

ATC

empagliflozin; oral

4.3

307.7

2422

6337

A10BX04

ATC

[U] exenatide

25.8

307.7

574

230

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

5.0

307.7

2535

5749

R4110

NOMESCO Finland

Physiotherapy

2.0

307.7

5141

29745

M79.6

ICD-10 Finland

Pain in limb

1.9

307.7

8040

53871

J01DB01

ATC

cefalexin; oral

2.4

307.7

15343

128738

C10AA01

ATC

simvastatin; oral

1.9

304.1

5627

35076

A10AE05

ATC

insulin detemir; parenteral

3.4

303.0

1177

3667

L15

ICPC

Knee symptom/complaint

2.0

302.7

4349

24912

J96.1

ICD-10 Finland

Chronic respiratory failure

7.0

298.5

461

675

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

298.0

6330

41143

A08

ICPC

Swelling

3.6

297.1

1035

3006

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

5.1

294.4

629

1261

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.4

294.0

2220

9848

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

6.3

293.7

498

804

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

4.3

293.2

788

1904

R02

ICPC

Shortness of breath/dyspnoea

2.3

291.5

2430

11258

WX110

NOMESCO Finland

Infiltration anesthesia

1.9

289.5

13234

107597

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.4

283.4

2225

10034

XCK10

NOMESCO Finland

Photography of fundus of eye

2.7

282.4

1717

6865

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.6

282.1

1748

7055

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.2

279.0

758

1846

S18

ICPC

Laceration/cut

1.8

278.7

7587

52788

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

276.0

3804

21382

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.2

275.3

2636

12921

J01DA01

ATC

[U] cefalexin

1.8

274.8

11267

87869

J01CE08

ATC

benzathine benzylpenicillin; parenteral

9.0

274.1

339

382

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.8

272.6

1523

5828

J01AA02

ATC

doxycycline; systemic

1.9

270.6

13777

114377

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.7

270.4

1652

6615

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.5

268.2

1888

8092

WX723

NOMESCO Finland

CPAP therapy

3.5

268.0

957

2822

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.2

267.2

2537

12382

JJA21

NOMESCO Finland

Laparoscopic biopsy of liver

25.4

266.7

186

N06AB10

ATC

escitalopram; oral

1.9

266.5

4415

26358

C09BA02

ATC

enalapril and diuretics; systemic

3.0

265.2

1297

4619

C02AC05

ATC

moxonidine; oral

3.7

263.6

859

2383

C08CA13

ATC

lercanidipine; oral

2.3

262.9

2257

10560

R03BA02

ATC

budesonide; inhalant

2.0

262.7

3523

19575

A10BH05

ATC

linagliptin; oral

3.7

261.1

850

2356

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.7

260.2

1535

6035

J01FA06

ATC

roxithromycin; oral

1.7

260.1

7213

50158

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.5

259.9

940

2794

WX290

NOMESCO Finland

Other blockage of nerve

1.7

259.7

9236

68750

J45

ICD-10 Finland

Asthma

2.3

259.5

2202

10248

J45.1

ICD-10 Finland

Nonallergic asthma

2.7

259.3

1472

5675

B01AA03

ATC

warfarin; systemic

2.2

257.9

2503

12311

B81

ICPC

Anaemia vit B12/folate deficiency

4.0

256.2

753

1942

R03BB04

ATC

tiotropium bromide; inhalant

2.6

255.1

1653

6805

A10BD07

ATC

metformin and sitagliptin; systemic

3.7

254.9

834

2319

4019X

ICD-9 Finland

Essential hypertension, Unspecified

5.6

254.5

486

880

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.9

252.3

1261

4542

H03AA01

ATC

levothyroxine sodium; systemic

1.9

252.2

4399

26627

N03AX12

ATC

[U] gabapentin; oral

2.1

251.8

3022

16111

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

250.9

6632

45378

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

9.4

250.9

301

326

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

3.2

247.1

1060

3499

OAB72, ,

SPAT

6.6

246.0

398

612

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.4

245.8

1935

8706

Z3229

NOMESCO Finland

Other healthcare associate professional

2.6

245.4

1551

6304

N05AX12

ATC

aripiprazole; systemic

3.2

243.7

1029

3365

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

243.0

6963

48596

N05BA04

ATC

oxazepam; oral

1.8

242.6

4795

30106

J46

ICD-10 Finland

Status asthmaticus

4.0

241.4

720

1876

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.3

241.4

2012

9277

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

7.9

240.7

331

425

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

3.1

238.4

1030

3413

AA40B, ,

NOMESCO Finland

14.4

237.0

214

150

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

234.3

4562

28463

R06.5

ICD-10 Finland

Mouth breathing

2.4

233.8

1770

7820

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

233.0

4576

28616

P76

ICPC

Depressive disorder

2.5

232.5

1602

6779

C09CA01

ATC

losartan; oral

1.9

231.9

3862

22949

K02.1

ICD-10 Finland

Caries of dentine

1.7

231.1

11035

87616

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.9

231.0

3443

19733

QBJ05

NOMESCO Finland

Other correction of loose or redundant skin of trunk

63.9

230.6

127

P06

ICPC

Sleep disturbance

2.1

229.2

2443

12425

A28

ICPC

Limited function/disability NOS

2.2

228.1

2274

11267

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

5.9

227.6

415

719

M54.4

ICD-10 Finland

Lumbago with sciatica

1.9

227.4

3461

19961

S76

ICPC

Skin infection other

3.0

226.6

1054

3643

N05CF01

ATC

zopiclone; oral

1.7

225.4

5291

34783

J01MA12

ATC

levofloxacin; systemic

2.0

224.2

3025

16747

R03DC03

ATC

montelukast; oral

1.9

223.7

3333

19077

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.1

223.6

2638

13924

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.0

221.9

2764

14874

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.1

221.5

2560

13408

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

5.1

219.9

467

930

Z2221

NOMESCO Finland

Medical doctor

1.7

218.9

5102

33418

N06AX11

ATC

mirtazapine; oral

1.7

218.9

6083

41802

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

218.5

3371

19501

R60.9

ICD-10 Finland

Oedema, unspecified

2.9

217.9

1057

3738

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

217.8

2111

10332

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.2

217.6

925

3033

Z71.8

ICD-10 Finland

Other specified counselling

1.7

214.5

5790

39431

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

214.2

4065

25065

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.8

213.7

1117

4113

N06AB06

ATC

sertraline; oral

2.1

213.2

2376

12264

C09AA05

ATC

ramipril; oral

1.9

212.9

3370

19638

R03AC03

ATC

terbutaline; inhalant

2.0

212.3

2714

14721

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

211.3

3668

21999

M25.5

ICD-10 Finland

Pain in joint

1.7

211.1

6013

41493

N03AX09

ATC

lamotrigine; oral

2.7

210.7

1193

4579

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

5.9

209.5

378

648

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.3

209.0

1819

8515

F50.8

ICD-10 Finland

Other eating disorders

10.8

208.7

225

210

ZXD05

NOMESCO Finland

Urgent procedure

1.7

208.0

5482

37030

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

3.8

207.9

660

1795

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

207.7

2408

12605

R03BA05

ATC

fluticasone; inhalant

1.9

205.9

3415

20174

SPAT1139

SPAT

Nutrition survey

3.6

204.8

697

1987

L03

ICPC

Low back symptom/complaint

1.7

204.6

5013

33174

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.7

203.4

4926

32486

C09DA01

ATC

losartan and diuretics; oral

2.3

202.7

1700

7830

M01AB05

ATC

diclofenac; systemic, rectal

1.6

202.4

11692

95754

EBA00

NOMESCO Finland

Extraction of tooth

1.7

201.4

6254

43998

RD112, ,

NOMESCO Finland

19.9

200.4

154

T07

ICPC

Weight gain

4.9

200.3

452

948

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.7

200.0

5631

38615

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.6

198.9

10042

79411

M03BX02

ATC

tizanidine; oral

1.6

198.4

11385

92838

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

197.0

1981

9815

N05AA02

ATC

levomepromazine; systemic

3.2

196.7

818

2645

Z02.7

ICD-10 Finland

Issue of medical certificate

2.5

196.7

1361

5755

H02AB07

ATC

prednisone; oral

2.0

196.6

2387

12685

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.7

196.5

4487

29066

P03

ICPC

Feeling depressed

2.1

195.5

2197

11352

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.0

193.3

2396

12823

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.4

192.5

1460

6433

M01AE02

ATC

naproxen; oral, rectal

1.6

192.5

10236

81658

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

4.4

192.4

495

1154

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.4

192.1

1420

6185

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

4.8

191.8

444

951

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

3.5

191.5

688

2031

ACC51

NOMESCO Finland

Release of median nerve

2.3

189.6

1502

6744

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.8

189.6

3897

24472

A10BX01

ATC

guar gum; oral

3.7

189.1

614

1695

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.7

188.9

4288

27684

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

188.8

2330

12442

C09DA06

ATC

candesartan and diuretics; oral

2.5

187.2

1290

5441

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

186.0

2192

11511

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.5

185.3

1209

4969

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

185.0

3438

20945

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.5

184.8

1267

5330

R05FB02

ATC

cough suppressants and expectorants; systemic

1.6

184.6

6001

42473

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.3

183.8

1607

7519

J01MA02

ATC

ciprofloxacin; systemic

1.6

182.7

6219

44484

I50

ICD-10 Finland

Heart failure

4.5

182.6

449

1010

A06AD11

ATC

lactulose; oral

2.1

181.9

2073

10749

WX402

NOMESCO Finland

General anaesthesia

1.7

181.6

3847

24325

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.5

181.5

656

1944

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.7

178.9

4519

29953

Z2446

NOMESCO Finland

Social worker

2.5

178.7

1258

5354

C10AA05

ATC

atorvastatin; oral

1.6

178.4

5633

39506

SFA30

NOMESCO Finland

Three-surface restoration

1.6

178.1

7367

55073

R03DA04

ATC

theophylline; systemic, rectal

3.0

177.9

820

2813

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

177.6

9349

73799

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

176.6

5991

42731

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

175.1

7254

54184

A10AD05

ATC

insulin aspart; parenteral

5.8

174.1

319

555

H3600, E113,

ICD-10 Finland

7.2

174.0

258

361

O10.0

ICD-10 Finland

Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium

4.2

173.8

478

1172

K04.08

ICD-10 Finland

Other specified pulpit

2.2

173.8

1653

7995

A02BC01

ATC

omeprazole; systemic

1.7

173.7

4452

29583

A12BA01

ATC

potassium chloride; oral

3.6

173.7

603

1740

S80.0

ICD-10 Finland

Contusion of knee

2.2

173.5

1521

7118

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

173.1

2032

10638

M01AH05

ATC

etoricoxib; oral

1.6

172.4

10930

89691

M48.0

ICD-10 Finland

Spinal stenosis

2.1

171.9

1725

8517

J20

ICD-10 Finland

Acute bronchitis

2.1

171.7

1926

9917

A10BG02

ATC

rosiglitazone; oral

6.5

171.4

283

444

N05BA01

ATC

diazepam; systemic, rectal

2.0

171.3

2205

11921

C09CA06

ATC

candesartan; oral

1.7

170.5

3972

25717

K04.0

ICD-10 Finland

Pulpitis

2.0

170.2

1991

10406

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.1

169.6

1870

9566

K07

ICPC

Swollen ankles/oedema

3.2

169.3

715

2331

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

168.5

4657

31507

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

168.2

8542

66572

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

5.6

168.0

319

574

207

Kela drug reimbursment

Chronic arrhythmias

2.1

167.1

1813

9217

SPAT1229

SPAT

Assessment of need for aid

2.4

166.2

1170

4975

R01AD09

ATC

mometasone; nasal

1.5

165.8

8364

65011

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

5.2

165.7

348

686

D01AC02

ATC

miconazole; topical

2.3

165.5

1288

5728

R06AE07

ATC

cetirizine; oral

1.5

165.3

7991

61522

SGA01

NOMESCO Finland

Emergency treatment

1.8

165.1

3227

19877

P01AB01

ATC

metronidazole; oral, rectal

1.6

165.0

7192

54113

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

164.7

3574

22668

40199

ICD-8 Finland

Essential benign hypertension

5.5

163.8

320

591

M02AA07

ATC

piroxicam; topical

1.6

163.8

5551

39418

N05CD07

ATC

temazepam; oral

2.1

163.2

1651

8170

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.2

162.9

1441

6762

SPAT1254

SPAT

Administration of medicine

1.9

162.5

2258

12512

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

161.6

2244

12430

D11

ICPC

Diarrhoea

1.9

160.1

2334

13134

ZXA00

NOMESCO Finland

Right side

1.7

158.4

3934

25830

N02AA05

ATC

oxycodone; systemic

1.9

158.0

2388

13591

F34.1

ICD-10 Finland

Dysthymia

2.8

157.8

829

3052

M70.6

ICD-10 Finland

Trochanteric bursitis

1.9

157.2

2191

12144

A01

ICPC

Pain general/multiple sites

2.1

156.9

1590

7869

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

156.2

2855

17218

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.4

155.7

1107

4725

J01CE02

ATC

phenoxymethylpenicillin; oral

1.6

155.1

12199

103710

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

153.6

9474

76369

C07AB02

ATC

metoprolol; systemic

1.8

153.4

2654

15738

S10

ICPC

Boil/carbuncle

2.4

153.0

1078

4582

WX002

NOMESCO Finland

Sedation and analgesia

1.8

152.0

2978

18308

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.0

152.0

1813

9522

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

151.6

1228

5549

R96

ICPC

Asthma

2.1

151.3

1658

8444

SFA20

NOMESCO Finland

Two-surface restoration

1.5

151.2

10548

87117

O24.1

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent

8.0

151.2

204

256

ZXE00

NOMESCO Finland

One hour or less

1.5

151.2

6578

49198

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.8

151.0

473

1273

S29

ICPC

Skin symptom/complaint other

1.7

150.7

3067

19055

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.2

150.2

623

2008

ZY010

NOMESCO Finland

Hospital outpatient

2.4

150.1

1083

4652

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

149.7

4099

27533

N06AA09

ATC

amitriptyline; systemic

2.1

148.7

1568

7870

XA420

NOMESCO Finland

Extensive sleep examination

5.6

148.6

286

521

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

146.9

3799

25134

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.8

146.8

759

2769

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.8

146.7

793

2962

H02AB04

ATC

methylprednisolone; systemic

1.8

146.6

2445

14324

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

146.2

4718

32939

M10.0

ICD-10 Finland

Idiopathic gout

3.5

146.2

513

1490

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

145.2

4864

34245

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.5

144.6

1002

4225

R03BA01

ATC

beclometasone; inhalant

1.8

144.5

2417

14166

N02BF01

ATC

gabapentin; oral

2.1

144.3

1456

7185

L30.4

ICD-10 Finland

Erythema intertrigo

4.9

143.6

323

675

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

143.5

4191

28551

R53

ICD-10 Finland

Malaise and fatigue

1.6

143.0

4083

27659

M10

ICD-10 Finland

Gout

3.0

143.0

665

2290

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.9

142.9

1977

10911

N62

ICD-10 Finland

Hypertrophy of breast

2.5

142.4

919

3747

A10BD03

ATC

metformin and rosiglitazone; systemic

5.6

142.1

272

493

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

142.1

2067

11593

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.4

142.0

1047

4539

R51.80

ICD-10 Finland

Headache

1.7

141.2

2936

18314

N06AX26

ATC

vortioxetine; oral

2.1

140.9

1482

7427

L90

ICPC

Osteoarthrosis of knee

2.4

140.7

997

4246

J01FA09

ATC

clarithromycin; systemic

1.5

140.3

5491

39969

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

6.1

139.6

242

399

N06AX03

ATC

mianserin; oral

2.6

139.0

847

3359

A02BC03

ATC

lansoprazole; oral

1.6

138.9

4457

31007

M79.7

ICD-10 Finland

Fibromyalgia

2.7

138.0

794

3061

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

137.9

6481

49004

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

137.5

2305

13503

SPAT1310

SPAT

Counselling related to known health issue

1.5

137.3

5098

36644

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

137.2

1515

7726

J01CF05

ATC

flucloxacillin; systemic

2.3

136.4

1111

5027

L16

ICPC

Ankle symptom/complaint

1.9

136.2

1984

11124

WX110, ,

SPAT

2.2

136.0

1198

5599

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

135.9

12876

112041

B01AF02

ATC

apixaban; oral

2.0

135.2

1515

7765

M54

ICD-10 Finland

Dorsalgia

1.8

135.1

2330

13762

WZC30

NOMESCO Finland

Teaching

1.8

134.6

2484

14965

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

134.2

4279

29688

H3601, E113,

ICD-10 Finland

5.3

133.9

273

524

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

133.6

4918

35239

N05AX08

ATC

risperidone; systemic

2.2

132.7

1246

5973

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.5

132.5

470

1374

C09CA03

ATC

valsartan; oral

2.1

131.4

1328

6548

R5110, ,

SPAT

2.4

131.3

994

4357

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.0

130.3

1604

8495

EB1AA, ,

SPAT

2.1

130.0

1292

6329

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.1

130.0

1354

6753

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.5

129.7

896

3769

M01AH01

ATC

celecoxib; oral

1.7

129.0

2787

17525

ZXA05

NOMESCO Finland

Left side

1.6

128.9

3544

23703

SFA10

NOMESCO Finland

One-surface restoration

1.5

128.1

9624

79414

SPAT1240

SPAT

Therapeutic discussion

1.8

126.9

2082

12097

C08CA02

ATC

felodipine; oral

2.2

126.9

1193

5718

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.4

126.9

958

4192

L60.0

ICD-10 Finland

Ingrowing nail

2.5

126.9

861

3591

N02BF02

ATC

pregabalin; oral

2.3

126.8

1068

4897

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.8

126.7

2264

13492

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

3.6

126.3

430

1224

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

125.5

1506

7903

UJF32

NOMESCO Finland

Coloscopy

1.6

125.3

3832

26265

D07AC01

ATC

betamethasone; topical

1.5

125.2

5835

43816

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.9

125.2

373

969

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.9

124.9

1789

9960

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

124.1

2745

17351

R03AC12

ATC

salmeterol; inhalant

2.6

124.0

732

2856

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.0

123.8

1474

7711

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

4.1

123.6

342

842

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.6

123.5

751

2973

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

122.7

4712

33954

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.0

122.4

1365

6975

SPAT1263

SPAT

Sampling

1.5

122.4

6827

53055

F50.3

ICD-10 Finland

Atypical bulimia nervosa

6.7

122.3

194

292

LCA06

NOMESCO Finland

Biopsy of endometrium

1.8

122.2

2268

13655

C01DA14

ATC

isosorbide mononitrate; oral

1.9

122.1

1571

8440

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

121.8

2449

15080

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

121.5

1705

9426

F32.1

ICD-10 Finland

Moderate depressive episode

2.1

120.9

1270

6348

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

120.8

1920

11039

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

120.6

3949

27455

A10BX09

ATC

[U] dapagliflozin

6.1

119.6

208

344

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

119.6

1185

5794

RD160, ,

NOMESCO Finland

15.4

119.5

104

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.6

119.2

705

2753

A10BH02

ATC

vildagliptin; oral

4.3

119.2

314

745

A02BC05

ATC

esomeprazole; systemic

1.5

118.8

6545

50657

E0000UV, ,

ATC

1.5

118.5

6975

54661

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

118.5

6475

50030

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.7

117.8

663

2525

SPAT1255

SPAT

Intravenous administration of medicine

2.2

117.7

1067

5037

F32

ICD-10 Finland

Depressive episode

2.1

117.7

1141

5531

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.2

117.3

1104

5290

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

117.0

1177

5787

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

116.6

3087

20395

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.8

116.5

615

2266

R05

ICPC

Cough

1.6

116.1

3944

27611

C01AA05

ATC

digoxin; systemic

2.4

116.1

818

3469

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.0

116.0

1423

7515

N06AX05

ATC

trazodone; oral

3.0

115.5

542

1874

F31.8

ICD-10 Finland

Other bipolar affective disorders

3.3

115.5

456

1426

J01CA04

ATC

amoxicillin; systemic

1.6

115.3

14359

129465

N05AN01

ATC

lithium; oral

3.0

114.8

514

1731

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

6.2

114.3

197

323

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

114.3

2394

14887

M01AX05

ATC

glucosamine; oral

1.7

114.0

2363

14652

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

3.6

114.0

379

1062

SPAT1301

SPAT

No procedures

1.5

113.8

4747

34698

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.2

113.5

1049

4990

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.3

113.3

447

1397

SPAT1211

SPAT

Application of soft bandage

2.0

113.2

1345

7023

R06.2

ICD-10 Finland

Wheezing

2.4

113.1

800

3398

C07AG02

ATC

carvedilol; oral

2.5

111.9

761

3175

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.8

111.8

1764

10106

M01AB01

ATC

indometacin; systemic, rectal

2.2

111.6

961

4442

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

3.1

111.4

480

1581

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

111.0

2575

16439

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.6

110.9

3439

23552

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

110.1

1999

11937

P99

ICPC

Psychological disorders other

2.7

109.9

616

2341

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.7

109.9

624

2387

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.3

109.8

889

4005

M01AC06

ATC

meloxicam; systemic, rectal

1.5

109.7

5685

43312

F50.4

ICD-10 Finland

Overeating associated with other psychological disturbances

31.0

108.8

C02EA02, ,

ATC

3.0

108.7

501

1715

D64.9

ICD-10 Finland

Anaemia, unspecified

2.0

108.6

1342

7100

K08.3

ICD-10 Finland

Retained dental root

2.1

108.4

1162

5845

SPAT1283

SPAT

Restricted health certificate

1.6

108.2

3550

24606

RK320, ,

NOMESCO Finland

6.3

107.9

182

292

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

107.7

2129

13014

R74

ICPC

Upper respiratory infection acute

1.4

107.6

5981

46134

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.5

107.6

380

1108

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

4.8

107.5

244

514

L14

ICPC

Leg/thigh symptom/complaint

2.0

107.3

1237

6387

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.8

107.3

1614

9107

O13

ICD-10 Finland

Gestational [pregnancy-induced] hypertension

2.2

106.6

927

4301

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

106.5

2872

19017

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.4

106.4

783

3384

JAF30

NOMESCO Finland

Repair of umbilical hernia using prosthetic material

3.3

106.4

418

1303

N05AF03

ATC

chlorprothixene; systemic

2.9

106.4

507

1768

JAH01

NOMESCO Finland

Laparoscopy

2.2

106.4

919

4252

W85

ICPC

Gestational diabetes

2.3

106.3

840

3744

JDF97

NOMESCO Finland

Other laparoscopic bariatric operation on stomach

+∞

106.3

102

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.7

106.3

2012

12149

R03AC13

ATC

formoterol; inhalant

2.3

106.1

840

3748

F61.0

ICD-10 Finland

Mixed personality disorders

3.3

106.0

404

1236

L73.2

ICD-10 Finland

Hidradenitis suppurativa

4.2

105.7

285

688

R73.0

ICD-10 Finland

Abnormal glucose tolerance test

3.2

105.6

425

1344

CL2S4, ,

SPAT

4.1

105.4

294

728

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.4

105.0

754

3223

O36.6

ICD-10 Finland

Maternal care for excessive fetal growth

2.4

105.0

743

3156

J01MA14

ATC

moxifloxacin; systemic

1.9

104.6

1403

7627

A04

ICPC

Weakness/tiredness general

1.7

104.3

2319

14621

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.4

104.0

734

3113

J45.8

ICD-10 Finland

Mixed asthma

2.7

103.9

563

2102

M01AX17

ATC

nimesulide; oral

1.5

103.0

3372

23328

A08AA04

ATC

dexfenfluramine; oral

13.8

103.0

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

102.1

3850

27452

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.7

101.8

560

2107

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

5.3

101.6

203

383

H01

ICPC

Ear pain/earache

1.7

100.8

2023

12405

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.7

100.5

1958

11906

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

100.5

4407

32387

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

100.5

2337

14898

J01FA10

ATC

azithromycin; systemic

1.4

100.3

10175

86827

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.8

100.1

1620

9338

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.8

100.1

1605

9226

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

99.9

1979

12090

N05CF02

ATC

zolpidem; oral

1.6

99.0

2945

19920

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.8

98.9

1715

10087

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

98.8

796

3576

WX320

NOMESCO Finland

Spinalanesthesy

1.5

98.6

3592

25401

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.8

98.5

522

1927

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.4

98.4

723

3122

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

98.4

7121

57315

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.1

98.2

414

1346

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

97.8

3558

25148

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.3

97.8

370

1127

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.8

97.7

1747

10366

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.9

97.7

1333

7282

R11

ICD-10 Finland

Nausea and vomiting

1.9

97.5

1404

7803

B01AB10

ATC

tinzaparin; parenteral

1.8

97.4

1540

8810

J01DA06

ATC

[U] cefuroxime

1.6

97.1

2348

15105

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

97.0

1510

8598

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.0

96.9

1141

5930

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.5

96.8

343

1002

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.6

96.5

602

2410

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.5

95.9

641

2651

W84

ICPC

Pregnancy high risk

2.3

95.6

739

3261

J01DA09

ATC

[U] cefadroxil

1.5

95.3

4415

32735

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

4.3

95.3

247

579

C09DA03

ATC

valsartan and diuretics; oral

2.4

95.2

673

2856

SPAT1260

SPAT

Consultation of another employee

1.6

95.2

2658

17700

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.7

95.1

2011

12492

A08AA01

ATC

phentermine; oral

8.4

94.9

123

147

P29

ICPC

Psychological sympt/compl other

1.9

94.5

1323

7285

Z01.7

ICD-10 Finland

Laboratory examination

1.6

94.1

2367

15367

A03

ICPC

Fever

1.6

94.1

2988

20484

N05AB03

ATC

perphenazine; systemic, rectal

2.5

93.7

601

2438

A41.9

ICD-10 Finland

Sepsis, unspecified

2.7

93.3

501

1862

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

4.4

93.2

233

531

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.9

93.2

1323

7317

D07BC01

ATC

betamethasone and antiseptics; topical

1.7

93.0

1865

11417

R50.9

ICD-10 Finland

Fever, unspecified

1.6

92.9

2291

14796

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.1

92.6

875

4192

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.6

92.6

2225

14279

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.4

92.5

669

2868

E000001, ,

ATC

1.5

92.3

3265

22903

G44.2

ICD-10 Finland

Tension-type headache

1.6

91.9

2436

16009

RD140, ,

NOMESCO Finland

314.6

91.9

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.6

91.7

553

2178

T45

ICPC

Metabolic, Observ/health educat/advice/diet

3.9

91.6

274

714

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

5.1

91.4

194

386

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.0

91.2

1027

5252

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.3

91.1

358

1116

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.4

91.0

327

964

I50.1

ICD-10 Finland

Left ventricular failure

2.6

90.9

542

2123

K04.1

ICD-10 Finland

Necrosis of pulp

1.7

90.9

1890

11680

A10BD20

ATC

metformin and empagliflozin; oral

4.1

90.0

252

626

SGC10

NOMESCO Finland

Pulp capping

1.7

90.0

1633

9720

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.3

89.9

718

3212

R01AD08

ATC

fluticasone; nasal

1.4

89.9

4887

37254

B01AF01

ATC

rivaroxaban; oral

1.8

89.7

1536

8991

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.4

89.2

622

2622

S21

ICPC

Skin texture symptom/complaint

1.6

89.2

2090

13318

Z2445

NOMESCO Finland

Psychologist

2.3

89.0

738

3354

K85

ICPC

Elevated blood pressure

1.7

88.8

2018

12760

AA1AD

NOMESCO Finland

CT of head and brain

1.5

88.5

3526

25323

L08

ICPC

Shoulder symptom/complaint

1.5

88.4

3266

23094

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.1

88.3

868

4220

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.8

88.3

1438

8291

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.3

88.1

708

3176

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.0

87.9

408

1402

ZXA10

NOMESCO Finland

Bilateral

1.6

87.8

2575

17314

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

6.2

87.7

150

244

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.7

87.7

1907

11918

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.7

87.7

502

1927

N05AH03

ATC

olanzapine; systemic

2.0

87.6

1055

5522

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

87.4

2309

15148

G93.2

ICD-10 Finland

Benign intracranial hypertension

9.9

87.1

100

102

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3.3

87.1

333

1021

C08DB01

ATC

diltiazem; oral

2.5

87.0

570

2335

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.7

86.8

468

1742

D07XC01

ATC

betamethasone; topical

1.7

86.4

1785

11004

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

2.8

86.2

431

1542

N03AG01

ATC

valproic acid; systemic, rectal

2.0

86.0

993

5121

L68.0

ICD-10 Finland

Hirsutism

4.9

85.9

189

388

N03AX11

ATC

topiramate; oral

2.5

85.8

539

2165

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

3.0

85.8

381

1277

SPAT1216

SPAT

Assessment of functional ability

1.7

85.6

1890

11854

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.4

85.4

601

2544

M01AH02

ATC

rofecoxib; oral

1.7

85.1

1696

10351

K10.3

ICD-10 Finland

Alveolitis of jaws

2.0

85.0

911

4574

R42

ICD-10 Finland

Dizziness and giddiness

1.5

84.4

3228

22960

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.1

84.4

799

3828

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.2

84.4

735

3407

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.3

83.9

314

950

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

15903

137353

2.50

309.63

6.3

4.6

2.13

2.06

mu/l

0.14

15156

128324

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

257

155

16.81

308.29

1.0

1.1

70.88

87.42

ug/l

4.93

228

120

(3024561) Albumin [Mass/volume] in Serum or Plasma

10249

54461

3.08

307.65

5.4

4.7

35.67

36.20

g/l

20.41

9793

50709

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

6390

31991

2.56

307.65

2.7

2.1

3.17

2.78

mg/l

28.48

5704

27427

(3012516) Albumin [Mass/volume] in Urine

7044

32608

2.92

307.65

3.6

3.2

198.26

478.07

mg/l

9.44

4990

20355

(1002224) Polysomnography panel

1932

6462

3.23

307.65

1.1

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

11392

77762

2.30

307.65

6.0

4.3

7.01

6.50

mmol/l

87.88

10798

71732

(3012095) Magnesium [Moles/volume] in Serum or Plasma

5030

19369

3.23

307.65

3.0

3.5

0.82

mmol/l

1.07

4798

18223

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

5773

29126

2.45

307.65

3.4

2.7

1088.65

1106.54

ng/l

0.12

4765

24592

(3004789) Transferrin [Mass/volume] in Serum or Plasma

3812

17983

2.43

307.65

2.8

2.4

2.50

2.38

g/l

31.34

3551

16701

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

15951

128618

3.35

307.65

8.7

4.6

41.91

38.43

mmol/mol

283.85

15344

120607

(3007853) Bacteria identified in Skin by Aerobe culture

3407

15768

2.44

307.65

2.1

1.7

—

(3022948) Iron [Moles/volume] in Serum or Plasma

4086

19739

2.39

307.65

2.8

2.4

12.73

14.05

umol/l

25.90

3856

18511

(3033658) Prothrombin time (PT) actual/Normal

5971

34287

2.12

307.65

4.3

3.7

94.33

93.78

0.90

5791

33362

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

3553

16507

2.44

307.65

2.9

2.5

20.94

23.90

31.59

3166

14188

(3042936) Bacteria identified in Isolate by Culture

3534

17980

2.21

307.65

2.4

1.9

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

10286

68733

2.18

307.65

4.0

2.8

101.17

102.07

ug/l

0.06

9777

64745

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

9187

56357

2.30

307.65

7.3

5.6

1.21

mmol/l

11.01

8647

51804

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8082

47203

2.31

307.65

3.3

3.2

31.10

32.50

u/l

1.23

7745

44977

(3021960) Folate [Moles/volume] in Serum or Plasma

5661

26953

2.61

307.65

1.8

1.5

21.45

20.56

nmol/l

4.69

5194

23418

(3022217) INR in Platelet poor plasma by Coagulation assay

8624

55871

2.06

307.65

15.9

11.2

1.20

1.18

inr

0.70

2218

17060

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

9979

62685

2.35

307.65

7.8

6.2

1.21

1.22

mmol/l

15.92

8910

53470

(3015377) Calcium [Moles/volume] in Serum or Plasma

7017

43719

2.00

307.65

2.9

3.3

2.34

2.35

mmol/l

15.70

6305

39078

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

10000

57842

2.67

307.65

3.3

2.2

69.66

1618.61

nmol/l

0.50

9438

53177

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

13962

106773

2.44

307.65

8.2

7.1

80.89

75.14

u/l

46.76

13436

100985

(3044640) Blood type and Crossmatch panel - Blood

6812

44099

1.88

307.65

2.5

2.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

7345

34220

2.95

307.65

4.2

3.7

11.41

9.17

mg/mmol

2.57

5106

21402

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

14329

117035

2.16

307.65

5.1

4.0

14.50

14.54

pmol/l

1.15

13516

108399

(3018418) pH of Serum or Plasma

6323

37193

2.09

307.65

4.5

3.9

7.40

0.19

900

7092

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

9475

50402

2.88

307.65

2.6

1.8

94.03

97.93

pmol/l

13.49

5772

26246

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4513

14544

3.82

307.65

5.1

6.0

1.07

1.03

mmol/l

18.77

4327

13614

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2628

11304

2.55

307.65

2.4

2.3

0.22

g/l

2.11

2470

10576

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4661

26292

2.05

307.65

2.1

1.6

11890060.43

40089113.32

pmol/l

4.89

4096

22328

(3023368) Bacteria identified in Blood by Culture

5605

31429

2.14

307.65

4.8

4.0

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

5408

31817

2.01

307.65

2.1

1.7

0.99

1.06

mg/l

0.79

4212

23875

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

7145

46686

1.89

307.65

3.6

3.1

—

0.43

—

(3009508) Creatinine [Moles/volume] in Urine

7618

37140

2.84

307.65

3.5

3.1

8.04

7.70

mmol/l

7.34

6566

32028

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

10437

69360

2.22

307.65

5.7

5.9

10.55

10.72

umol/l

0.71

9967

65722

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2840

12702

2.47

307.65

2.1

2.2

337.53

378.96

nmol/l

22.94

2546

11769

(3019309) Folate [Moles/volume] in Red Blood Cells

4747

20188

2.84

307.65

2.2

1.6

1204.87

1167.92

nmol/l

2.04

4009

15440

(3026493) Urate [Moles/volume] in Serum or Plasma

6801

34009

2.62

307.65

2.7

2.3

3177.98

3424.27

umol/l

0.22

6063

30391

(3016244) Insulin [Units/volume] in Serum or Plasma

761

663

11.95

307.65

4.6

2.6

39.16

16.78

mu/l

27.59

737

615

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2250

10028

2.42

294.91

4.7

3.9

6.00

5.82

kpa

11.11

2186

9740

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

15981

139264

2.46

288.26

6.2

3.8

6.30

5.74

mmol/l

307.65

15178

129406

(40768797) Stomach Pathology biopsy report

3467

18609

2.07

287.45

1.2

—

(3012544) pH of Venous blood

2279

10376

2.37

284.10

4.7

3.9

7.35

7.38

1.34

(3002032) Base excess in Venous blood by calculation

2217

9993

2.39

282.63

4.7

3.9

2.05

1.86

mmol/l

1.39

1919

8493

(3027801) Oxygen [Partial pressure] in Arterial blood

2620

12684

2.25

282.61

8.6

7.2

11.24

13.13

kpa

68.81

2506

12139

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2621

12691

2.25

282.60

8.7

7.3

5.34

5.05

kpa

35.67

2513

12150

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

6436

42567

1.80

282.31

2.8

2.5

51.05

65.18

u/l

4.83

6003

39483

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1648

6470

2.71

280.95

4.0

3.2

5.33

5.10

kpa

19.24

1573

6138

(3009343) pH of Capillary blood

1630

6379

2.71

279.57

4.0

3.2

7.42

0.15

154

851

(3000991) Gas panel - Venous blood

2120

9447

2.41

276.98

10.0

8.5

—

(3003396) Base excess in Arterial blood by calculation

2599

12693

2.23

273.76

8.7

7.2

1.30

0.91

mmol/l

4.76

2154

10002

(3006315) Basophils [#/volume] in Blood

9627

71937

1.74

271.94

6.5

5.8

0.04

e9/l

2.91

8294

63087

(3001604) Monocytes [#/volume] in Blood

9606

71814

1.73

270.14

6.5

5.8

0.59

0.56

e9/l

26.27

8292

63073

(3026008) Bacteria identified in Urine by Culture

6013

39471

1.79

266.98

3.4

2.7

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

16543

147458

2.76

266.93

22.3

12.5

139.73

139.65

mmol/l

5.62

16343

143752

(3030467) Casts [#/volume] in Urine by Automated count

5588

35918

1.81

266.11

3.3

2.9

0.48

0.36

e6/l

3.22

4206

26854

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1566

6155

2.69

265.84

3.9

3.2

1.99

1.59

mmol/l

3.56

1186

4457

(3018095) Leukocytes [#/volume] in Urine

6947

47629

1.75

264.75

4.0

3.4

79.14

88.22

e6/l

0.51

4811

32437

(3023103) Potassium [Moles/volume] in Serum or Plasma

16566

147940

2.77

262.94

22.5

12.6

3.95

3.94

mmol/l

9.60

16358

143906

(3013650) Neutrophils [#/volume] in Blood by Automated count

10710

82890

1.73

262.33

9.1

8.9

4.58

3.96

e9/l

139.62

9257

72893

(3019198) Lymphocytes [#/volume] in Blood

9837

74388

1.72

261.97

6.5

5.8

2.02

1.93

e9/l

10.84

8680

66771

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

624

1380

4.65

259.61

1.2

27.20

33.90

nmol/l

—

(3024354) Oxygen [Partial pressure] in Venous blood

1871

8119

2.46

258.28

3.9

3.3

4.83

4.66

kpa

2.43

1810

7861

(3013115) Eosinophils [#/volume] in Blood

9836

74545

1.72

258.24

6.9

6.0

0.20

0.19

e9/l

19.23

8645

66345

(3014111) Lactate [Moles/volume] in Serum or Plasma

2156

9986

2.32

256.79

8.6

7.1

1.37

1.31

mmol/l

2.07

2102

9759

(3002582) Erythrocytes [#/volume] in Urine

5945

39317

1.77

254.49

3.4

3.0

50.28

72.10

e6/l

1.19

4501

29736

(3022313) Gas panel - Capillary blood

1249

4508

2.90

248.86

4.0

3.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

9117

68135

1.69

248.03

2.8

2.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

5195

33247

1.79

247.39

2.4

2.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

5463

35496

1.78

246.97

1.7

1.6

1.62

1.35

mmol/l

74.37

4820

30449

(3044889) 12 lead EKG panel

11966

96530

1.73

242.04

4.0

3.2

—

(40758558) Short blood count panel - Blood

5455

35661

1.76

240.05

6.7

6.8

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2892

15530

2.03

234.71

2.6

7.45

7.70

umol/l

0.25

2425

13351

(40760892) CBC W Ordered Manual Differential panel - Blood

8974

67680

1.66

228.21

6.6

6.3

—

(36304419) Bacteria [Presence] in Urine

5388

35542

1.74

227.07

3.2

2.8

—

(3016502) Oxygen saturation in Arterial blood

2264

11242

2.16

225.73

9.2

7.7

94.74

96.07

17.02

2199

10811

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3751

22387

1.86

220.72

2.7

2.9

2.44

mmol/l

0.43

3239

19617

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1887

8782

2.29

220.42

4.4

3.8

101.28

84.74

ng/l

9.02

1703

7719

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3654

21800

1.85

214.49

2.8

2.6

1.35

1.22

e6/l

0.43

1997

12135

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

12482

103326

1.70

213.93

3.9

2.9

51.78

41.48

u/l

30.95

11858

97936

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

768

2287

3.46

211.15

2.2

1.03

0.79

nmol/l

11.82

621

1956

(3037467) Urinalysis macro (dipstick) panel - Urine

12075

99345

1.67

209.04

4.9

4.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

11577

94272

1.65

208.17

5.2

4.0

1506.40

1693.96

e6/l

0.12

124

1117

(3020779) Urea [Moles/volume] in Serum or Plasma

2010

9859

2.17

205.61

8.6

7.5

10.56

8.58

mmol/l

23.70

1926

9459

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2407

12735

2.03

201.08

2.5

60.82

40.02

u/l

0.49

2011

11009

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1372

5781

2.49

199.88

10.7

9.6

24.71

24.20

mmol/l

6.41

1320

5643

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1071

4016

2.77

197.62

4.3

3.4

25.03

24.78

mmol/l

2.05

1014

3714

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3221

18971

1.85

194.84

1.9

1.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

6546

46902

1.63

193.98

4.1

3.0

54.59

54.71

ng/l

0.00

4037

26866

(3019069) Monocytes/100 leukocytes in Blood

8788

67707

1.59

191.19

6.9

6.2

7.91

8.35

39.69

8308

63791

(3006504) Eosinophils/100 leukocytes in Blood

8745

67318

1.59

190.80

6.6

5.9

2.78

2.84

1.75

8250

63292

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

453

992

4.66

190.47

1.6

1.3

1.72

1.42

nmol/l

5.13

423

883

(3011397) Hemoglobin [Presence] in Urine by Test strip

4900

32765

1.68

189.62

4.2

3.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3377

20342

1.81

189.24

2.9

2.7

5.43

3.12

e6/l

13.38

1735

10749

(3014007) Fractional oxyhemoglobin in Arterial blood

1546

7054

2.31

187.92

10.6

9.3

93.10

94.20

9.37

1540

7031

(3019060) Gas panel - Arterial blood

1542

7040

2.30

187.14

5.0

4.8

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

15553

138981

1.95

185.05

4.8

3.5

1.56

1.24

mmol/l

307.65

14727

130080

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

16193

146858

2.16

183.68

5.9

4.2

2.68

2.87

mmol/l

132.21

15469

137937

(3026782) Osmolality of Urine

3960

25235

1.73

181.81

3.0

2.7

565.51

533.96

mosm/kgh2o

13.37

3361

21655

(3018010) Neutrophils/100 leukocytes in Blood

8885

69151

1.57

181.12

6.5

5.8

58.66

56.54

66.23

8424

65281

(3002030) Lymphocytes/100 leukocytes in Blood

8984

70158

1.57

179.98

6.7

5.9

27.36

28.98

45.41

8518

66269

(3022096) Basophils/100 leukocytes in Blood

8448

65062

1.57

179.90

6.7

6.0

0.64

0.69

20.48

7922

60933

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1525

7058

2.27

178.87

10.7

9.1

1.45

1.38

1.51

1514

7015

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1519

7031

2.27

178.09

10.7

9.3

0.65

0.69

4.03

1508

6989

(3015736) pH of Urine

7678

57967

1.57

177.66

3.9

3.0

5.74

5.90

4.66

563

5775

(3021589) Normoblasts [#/volume] in Blood

8291

63712

1.56

177.35

10.2

8.6

0.00

e9/l

2.05

6607

52360

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3239

19647

1.79

175.87

1.8

1.7

1.42

1.39

1.50

2864

17561

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2026

10594

2.03

173.18

10.0

8.0

124.45

121.58

g/l

7.50

1994

10290

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

15998

144998

2.04

172.92

5.4

3.9

4.46

4.79

mmol/l

307.65

15319

136907

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

15924

144099

2.01

172.82

5.3

3.8

1.29

1.51

mmol/l

307.65

15169

135666

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

15382

137703

1.87

171.21

16.7

10.5

88.08

86.58

ml/min/173m2

12.34

13236

113354

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2313

12718

1.94

171.00

1.8

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2327

12837

1.94

170.31

1.8

1.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

755

2537

3.06

169.76

2.2

2.3

117.55

98.14

ug/min

0.49

457

1574

(3000850) Epithelial cells [#/volume] in Urine

4118

27040

1.68

167.13

2.7

2.4

7.65

6.23

e6/l

8.30

3656

24171

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1231

5350

2.40

166.66

5.2

4.3

24.28

24.12

mmol/l

0.89

1208

5247

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

16273

148740

2.12

166.54

19.6

11.7

21.92

21.56

mg/l

0.77

14754

114318

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

3025

18337

1.78

163.31

1.8

—

(3013707) Erythrocyte sedimentation rate by Westergren method

12596

107460

1.59

161.79

4.5

3.8

15.68

10.37

mm/h

266.73

11841

100622

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1712

8662

2.08

159.43

2.9

2.7

141.01

164.05

ng/l

2.22

1473

7819

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1140

4918

2.41

156.66

3.7

3.0

0.65

0.04

1134

4896

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1089

4615

2.45

155.64

4.6

3.7

51.52

49.29

2.09

1075

4568

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1156

5044

2.38

154.82

3.7

3.0

1.43

1.30

3.07

1150

5013

(3004119) Hemoglobin [Mass/volume] in Venous blood

1374

6539

2.19

149.57

4.2

3.3

130.18

129.90

g/l

0.17

1343

6393

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3617

23608

1.67

147.58

3.8

3.3

256.36

468.97

ng/l

2.35

2522

16058

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1327

6268

2.21

147.10

2.2

1.6

5.11

3.60

mg/l

3.47

1246

4327

(3009261) Glucose [Presence] in Urine by Test strip

9000

72184

1.50

146.56

4.3

3.3

0.01

0.00

estimate

0.84

1450

13415

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5329

38246

1.56

146.50

2.2

2.1

186.75

189.56

u/l

0.08

5033

36076

(3035350) Ketones [Presence] in Urine by Test strip

8919

71456

1.50

145.65

4.3

3.3

0.00

estimate

0.01

1616

14187

(3013139) Helicobacter pylori Ag [Presence] in Stool

1833

9841

1.96

143.85

1.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

8914

71539

1.49

143.45

5.7

4.5

0.00

estimate

0.13

1557

13681

(3020891) Body temperature

1014

4386

2.39

138.14

5.5

4.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

652

2271

2.94

137.29

2.6

2.9

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1650

8821

1.96

130.48

1.6

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1092

5015

2.25

129.21

3.9

3.4

25.38

25.23

mmol/l

0.71

1066

4862

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1294

6438

2.09

124.87

1.8

1.6

—

(3027945) Reticulocytes/100 erythrocytes in Blood

2097

12372

1.79

121.11

2.3

2.5

1.95

1.74

15.87

1843

11058

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1367

7224

1.97

111.10

1.7

1.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

4257

30576

1.52

110.44

1.4

2.53

2.26

g/l

15.22

2511

19496

(3000494) Fungus identified in Specimen by Culture

2536

16146

1.67

110.40

1.5

1.4

—

(3018405) Lactate [Moles/volume] in Arterial blood

865

3854

2.31

109.64

4.5

4.0

1.40

1.37

mmol/l

0.40

847

3791

(3013512) EKG study

4746

34953

1.49

108.68

4.3

3.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

786

3372

2.39

108.64

3.4

0.34

0.35

u/ml

0.05

430

1896

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4822

35685

1.48

107.56

1.3

1.60

1.64

u/ml

0.08

1248

10275

(3028717) Thiamine [Mass/volume] in Blood

117

114

10.32

105.29

1.3

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

188

327

5.80

102.67

2.0

1.2

17.56

16.73

umol/l

1.32

179

283

(40761535) Cells panel - Urine sediment

1761

10367

1.78

101.40

4.0

3.3

—

(3037522) Nuclear Ab [Titer] in Serum

3150

21532

1.56

101.34

1.4

521.71

552.77

titre

0.36

563

4401

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

16706

157797

1.98

100.70

13.2

9.2

30.18

25.81

u/l

94.73

16389

153045

(4200892) Spirometry reversibility

1633

9454

1.80

99.42

1.5

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2824

18979

1.58

97.42

2.2

2.1

30.17

29.53

5.90

2756

18392

(4146454) Self-monitoring of blood glucose

336

966

3.53

97.20

2.8

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

245

587

4.22

91.84

2.1

1.5

1.64

1.09

nmol/l

7.26

188

468

(44816559) Phosphatidylethanol [Mass/volume] in Blood

651

2770

2.40

91.50

1.3

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1264

6973

1.87

89.60

8.4

6.8

24.95

24.47

mmol/l

4.18

1218

6617

(3020630) Protein [Mass/volume] in Serum or Plasma

1539

9060

1.76

88.03

1.8

2.5

66.58

66.78

g/l

0.50

1423

8308

(3015235) Bicarbonate [Moles/volume] in Capillary blood

611

2589

2.41

86.64

3.2

2.7

25.20

24.46

mmol/l

3.63

598

2534

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1278

7150

1.85

86.56

8.5

7.0

25.33

24.68

mmol/l

6.70

1266

7099

(3034770) Mitochondria Ab [Titer] in Serum

820

3935

2.14

86.30

1.2

1.3

1196.92

899.24

titre

0.29

132

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

527

2095

2.56

85.71

1.1

42.48

5496.99

iu/ml

0.66

133

505

(3052851) Hemolysis interference index of Serum or Plasma

809

3878

2.14

85.37

3.0

2.9

—

(3043409) Potassium [Moles/volume] in Arterial blood

729

3363

2.22

84.73

4.8

4.3

3.88

3.85

mmol/l

0.66

722

3333

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2054

13236

1.62

83.44

3.5

4.3

230.45

237.72

u/l

1.71

1943

12575

(3019150) Specific gravity of Urine by Refractometry

4097

30639

1.44

82.41

4.8

3.6

1.02

kg/l

3.08

457

4540

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

685

3127

2.24

81.66

1.3

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

205

476

4.35

80.09

1.5

1.4

163.18

188.13

nmol/24h

0.11

205

476

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

821

4064

2.07

79.52

2.3

2.0

1.83

2.21

ug/l

0.53

735

3603

(3009214) Lutropin [Units/volume] in Serum or Plasma

949

5001

1.95

77.02

1.4

1.3

8.83

11.12

u/l

7.90

774

4129

(3023520) Reticulocytes [#/volume] in Blood

1487

9003

1.71

76.51

2.5

2.6

80.04

69.48

e9/l

17.94

1088

6712

(3017143) Hepatitis C virus Ab [Presence] in Serum

2804

19734

1.50

76.38

1.7

1.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

547

2343

2.38

75.67

2.9

2.8

8.28

8.44

kpa

1.40

539

2295

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3543

26147

1.44

75.56

1.3

10.13

11.11

u/ml

0.37

1369

10905

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3707

27602

1.43

75.28

1.3

26.66

32.96

iu/ml

1.54

1027

9053

(3007566) Smooth muscle Ab [Titer] in Serum

798

3995

2.04

74.90

1.2

1.3

113.52

136.25

titre

0.33

379

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1515

9278

1.69

74.64

2.4

2.2

5.77

7.49

ug/l

1.79

1282

8178

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

4404

33914

1.40

73.53

1.8

1.6

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

557

2454

2.31

72.21

1.4

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

556

2454

2.31

71.78

1.4

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1717

10980

1.62

71.29

3.0

2.4

70.90

71.12

ml/min/173m2

0.06

762

4078

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2283

15602

1.53

71.05

8.6

5.9

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

248

721

3.47

70.59

1.9

1.4

15.52

28.52

umol/l

13.40

241

690

(3002385) Erythrocyte distribution width [Ratio]

14167

130750

1.41

70.28

22.4

14.0

15.28

14.76

6.59

14033

128566

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

518

2247

2.34

69.61

1.7

1.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1351

8186

1.70

69.04

1.6

1.9

1.14

1.34

g/l

6.02

1245

7554

(3024928) Oxygen saturation in Venous blood

535

2362

2.30

69.02

4.3

3.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1625

10330

1.63

69.01

3.0

3.4

4.47

4.52

pmol/l

1.30

1442

9320

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1402

8598

1.68

68.47

2.7

2.1

8.49

12.13

nmol/l

57.42

1257

7764

(3037121) Protein [Mass/volume] in Urine

797

4135

1.97

67.57

2.9

3.2

0.34

0.31

g/l

0.59

407

1781

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

719

3629

2.02

65.90

1.8

1.7

34.07

44.15

nmol/l

15.99

696

3547

(3021387) Prolactin [Units/volume] in Serum or Plasma

1192

7098

1.73

64.78

1.7

1.6

300.38

312.51

mu/l

0.67

1049

6372

(3028707) Methadone [Presence] in Urine by Screen method

631

3063

2.10

64.28

2.2

2.8

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

905

4984

1.86

64.00

1.8

1.7

1.69

1.46

g/l

10.43

780

4300

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1001

5698

1.80

63.57

1.5

1.7

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

283

951

3.01

63.48

1.4

1.3

5.61

5.18

umol/l

1.04

262

876

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

216

619

3.52

62.90

1.8

1.6

3.27

16.41

nmol/l

0.80

173

513

(40761511) CBC panel - Blood by Automated count

16419

156757

1.62

61.85

17.9

10.9

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

487

2166

2.28

61.74

1.9

1.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1204

7313

1.69

60.73

1.7

2.3

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

125

243

5.17

60.61

1.4

5.46

5.76

nmol/l

0.35

118

230

(3005719) IgG [Mass/volume] in Serum or Plasma

1634

10722

1.58

60.40

2.3

2.7

10.57

10.50

g/l

0.32

1519

9844

(3009445) Proteinase 3 Ab [Units/volume] in Serum

963

5507

1.79

60.15

1.5

1.6

10.58

13.94

u/ml

0.49

165

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3826

29606

1.37

59.90

1.8

1.7

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

739

3894

1.94

59.79

2.4

2.3

438.95

502.73

ug/l

0.36

693

3599

(3021901) Oxygen saturation in Capillary blood

429

1842

2.36

59.02

2.9

2.6

—

(3029937) Albumin [Presence] in Urine by Test strip

4716

37788

1.34

58.56

4.9

3.7

0.01

0.00

estimate

0.70

1477

13352

(3019225) pH of Specimen

1761

11834

1.54

58.46

4.8

4.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1049

6204

1.73

58.27

13.3

9.4

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

666

3461

1.96

56.11

1.3

1.5

15.84

14.20

iu/ml

0.08

(3013005) Retinol [Moles/volume] in Serum or Plasma

207

626

3.33

55.47

1.8

1.7

1.85

1.97

umol/l

1.51

196

579

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

759

4135

1.87

55.44

1.6

2.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

759

4138

1.87

55.31

1.6

2.2

7.79

7.24

g/l

14.92

695

3778

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

758

4134

1.87

55.18

1.6

2.2

4.05

3.61

g/l

13.00

695

3776

(3024666) Lithium [Moles/volume] in Serum or Plasma

267

961

2.81

52.92

13.7

11.6

0.62

mmol/l

0.10

246

893

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

502

2420

2.11

52.06

1.9

1.8

145.48

190.45

pmol/l

14.86

459

2313

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

349

1447

2.44

51.94

7.2

6.5

11.15

11.36

mg/l

0.36

323

1337

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

613

3199

1.95

50.99

1.7

2.2

0.00

0.03

g/l

2.85

565

2927

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

6574

55891

1.28

50.75

4.6

3.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1379

9062

1.57

50.26

2.7

2.2

5256.47

5829.13

u/l

0.34

520

3664

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

658

3539

1.89

49.99

1.7

2.3

0.44

0.77

g/l

2.78

588

3084

(3011985) Renin [Units/volume] in Plasma

402

1803

2.26

49.98

1.6

83.25

56.80

mu/l

1.52

365

1635

(3023183) Ammonium ion [Moles/volume] in Plasma

490

2390

2.08

49.27

3.9

2.8

36.09

33.83

umol/l

1.17

449

2194

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

764

4332

1.80

48.98

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

769

4371

1.79

48.90

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

379

1674

2.29

48.88

1.7

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

698

3854

1.84

48.82

1.5

2.2

9.90

10.14

g/l

1.02

634

3471

(42529406) Shigella sp [Presence] in Stool by Culture

769

4379

1.79

48.59

1.2

—

(3036489) Thrombin time

903

5392

1.71

48.29

1.9

2.1

20.66

21.17

2.87

780

4620

(3000492) Spirometry study

2091

15083

1.44

48.23

1.5

1.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

707

3939

1.83

48.03

1.6

2.2

3.02

2.88

g/l

3.62

645

3581

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

294

1169

2.54

47.87

2.2

2.0

18.71

19.35

nmol/l

0.57

280

1109

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

606

3218

1.91

47.86

1.6

2.1

36.99

38.49

g/l

8.20

544

2852

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

565

2932

1.96

47.78

1.6

2.2

0.00

g/l

0.92

517

2670

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

770

4422

1.77

47.27

1.5

1.6

178.85

327.72

titre

0.76

180

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

557

2891

1.96

47.08

1.6

2.2

0.00

g/l

-0.00

514

2666

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1786

12573

1.47

46.77

3.9

2.9

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

673

3729

1.84

46.53

1.4

285.12

284.23

ug/g

0.04

378

2088

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

743

4257

1.78

45.96

2.5

2.7

4.03

3.54

g/l

14.17

702

4023

(1616796) Gas panel - Central venous blood

501

2530

2.01

45.81

3.8

3.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

338

1464

2.33

45.64

2.9

3.0

0.81

0.82

nmol/l

0.27

268

1084

(3000475) Leukocytes [#/volume] in Synovial fluid

556

2915

1.94

45.62

1.7

1.6

15615.51

11741.46

e6/l

0.86

371

2158

(3025941) Bacteria identified in Stool by Culture

1341

8944

1.54

45.58

1.3

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

642

3542

1.84

45.00

1.9

1.7

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

742

4289

1.76

44.52

2.3

2.5

185.56

178.71

1.39

704

4054

(3011288) Drugs identified in Urine by Screen method

837

5021

1.70

43.96

2.1

2.9

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

4347

35559

1.29

43.95

2.0

1.9

—

(3008037) Lactate [Moles/volume] in Venous blood

442

2172

2.06

43.58

3.8

2.8

1.61

1.53

mmol/l

1.03

434

2117

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

779

4608

1.72

43.06

2.0

2.3

95.25

93.51

1.29

739

4423

(3048689) Calprotectin [Mass/mass] in Stool

2641

20175

1.36

43.04

2.3

2.4

138.34

116.61

ug/g

2.93

2144

15904

(3012898) Urea [Moles/volume] in Urine

108

6.41

42.04

1.7

1.4

198.51

164.94

mmol/l

1.25

(3003694) ABO and Rh group [Type] in Blood

5316

44866

1.26

41.20

1.6

—

(3044941) Cell count panel - Synovial fluid

386

1853

2.11

40.52

1.5

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

494

2593

1.93

40.41

2.3

2.1

132.69

130.80

g/l

0.82

323

1872

(3009466) Valproate [Moles/volume] in Serum or Plasma

400

1949

2.08

40.37

6.1

5.2

355.25

374.38

umol/l

1.69

358

1691

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

358

1677

2.16

40.04

1.4

595.74

437.76

pmol/l

0.24

322

1458

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

437

2208

2.00

39.92

1.3

—

(40768441) Liver Pathology biopsy report

252

1019

2.49

39.68

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

854

5302

1.64

39.27

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

567

3159

1.82

38.51

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

175

598

2.95

38.28

1.9

2.1

141.04

138.35

umol/l

0.03

291

(3034860) Kappa light chains.free [Mass/volume] in Serum

558

3114

1.82

37.69

1.9

3.4

54.17

67.80

mg/l

0.33

458

2527

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

557

3110

1.82

37.56

1.9

3.4

37.52

43.02

mg/l

0.53

455

2535

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

972

6304

1.57

37.26

1.1

1.82

10.93

u/ml

1.15

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

542

3031

1.81

36.37

1.8

3.3

3.16

2.39

ratio

0.17

268

(3005322) IgE [Units/volume] in Serum or Plasma

1463

10382

1.45

36.32

1.3

235.73

221.33

u/ml

0.16

1369

9622

(3020876) Protein [Mass/time] in 24 hour Urine

267

1155

2.33

36.25

2.2

2.5

1.38

1.36

g/24h

0.05

125

571

(36660697) Celiac disease serology panel - Serum

1729

12661

1.40

36.01

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1682

12265

1.41

35.89

1.2

135.91

151.20

iu/ml

0.84

594

4853

(1001926) Buprenorphine [Presence] in Urine by Screen method

888

5695

1.59

35.70

1.9

2.2

—

(3038515) Glucose [Moles/volume] in Venous blood

400

2039

1.98

35.67

4.1

2.9

7.60

7.46

mmol/l

0.47

394

1993

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

152

500

3.06

35.59

1.9

2.1

226.79

91.73

ug/min

0.39

107

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

756

4670

1.65

35.44

1.6

1.8

0.26

0.23

g/l

20.66

712

4451

(3021788) Differential panel - Synovial fluid

427

2232

1.94

35.39

1.6

1.5

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

772

4814

1.63

34.85

1.6

1.8

1.34

1.16

g/l

50.11

734

4600

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1729

12758

1.39

34.35

1.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

925

6064

1.55

33.77

2.2

2.0

38.44

39.39

u/l

0.74

819

5500

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

819

5230

1.59

33.52

2.1

1.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2012

15297

1.36

33.12

5.3

3.9

30.45

32.50

16.06

1644

10971

(3004716) Salmonella sp identified in Stool by Organism specific culture

1258

8833

1.46

32.94

1.4

—

(21494755) Public health laboratory ask at order entry panel

1462

19883

0.71

32.76

1.4

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1524

11111

1.41

32.41

1.3

21.10

28.56

iu/l

22.20

1248

9687

(4034850) Laboratory test

726

4540

1.62

32.40

11.2

8.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

460

2541

1.83

32.16

1.3

1.2

3.38

3.28

u/ml

0.03

129

873

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

705

4391

1.63

31.98

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

288

1355

2.14

31.95

1.1

1.0

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

256

1150

2.24

31.86

1.2

176.32

202.57

titre

0.18

222

(3010838) Calcium [Moles/time] in 24 hour Urine

448

2469

1.84

31.56

2.0

1.9

5.18

5.23

mmol/24h

0.10

394

2223

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

11915

111206

1.22

31.15

3.8

3.3

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

719

4531

1.61

31.09

6.2

4.9

1.77

1.71

0.47

684

4229

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

445

2460

1.83

31.05

1.3

1.2

4.75

3.92

u/ml

0.51

178

1083

(3033705) Calcium.ionized [Moles/volume] in Venous blood

254

1150

2.23

31.03

2.7

2.1

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

253

1148

2.22

30.74

1.2

105.71

112.14

titre

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

272

1272

2.16

30.66

1.2

1.3

—

titre

—

(3017569) Oxygen content in Arterial blood

132

441

3.01

30.16

2.2

2.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

593

3592

1.67

30.00

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

788

5127

1.56

29.73

2.1

2.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1379

10026

1.41

29.71

4.0

3.5

1.22

1.23

mmol/l

6.04

1206

8788

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

338

1733

1.97

29.71

1.2

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

327

1675

1.97

28.84

1.2

37.88

33.23

u/l

0.17

289

1467

(3016879) Cocaine [Presence] in Urine

995

6869

1.48

28.36

1.9

2.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

212

925

2.31

28.33

1.4

2.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

699

4474

1.59

28.32

6.3

4.9

0.83

0.91

6.17

669

4179

(3000764) Benzodiazepines [Presence] in Urine

1062

7442

1.45

28.01

1.9

2.1

—

(3022145) Colonoscopy Study observation

2013

15664

1.32

28.01

1.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

362

1938

1.89

27.99

1.2

1.3

0.15

0.21

nmol/l

1.05

113

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

362

1938

1.89

27.99

1.2

1.3

0.57

1.81

nmol/l

0.91

346

1872

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

722

4669

1.57

27.98

2.0

1.8

—

(3000330) Specific gravity of Urine by Test strip

896

6073

1.50

27.97

3.6

3.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

428

2418

1.79

27.83

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

463

2688

1.74

27.40

4.5

3.8

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

434

2474

1.77

27.38

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

548

3332

1.67

27.35

1.5

1.3

15.45

28.87

u/l

31.61

459

2718

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

427

2429

1.78

27.13

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

945

6516

1.48

27.08

2.4

2.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

376

2068

1.84

26.72

1.2

1.3

—

(3027008) Opiates [Presence] in Urine

1059

7486

1.44

26.64

1.9

2.0

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

610

3836

1.61

26.62

2.2

2.1

11.53

10.62

mg/l

2.14

561

3598

(3028300) Cannabinoids [Presence] in Urine

1061

7508

1.44

26.54

1.9

2.1

—

(3036603) Volume of Urine

194

840

2.32

26.42

1.5

1.6

2011.51

1991.82

0.10

189

822

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

423

2423

1.76

26.26

1.6

—

(3010421) pH of Blood

514

3117

1.67

25.93

4.8

3.4

7.42

0.89

452

2843

(3002256) Pathology report gross observation

2343

18815

1.28

25.57

1.2

—

(3027944) Amphetamines [Presence] in Urine

1039

7388

1.43

25.30

1.8

2.0

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

934

6537

1.45

24.76

2.7

2.5

0.49

0.24

e6/l

2.55

898

6317

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

406

2355

1.74

24.15

1.1

125.95

118.28

4.49

362

2143

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

899

6278

1.45

24.12

1.9

1.7

—

(40757494) Bilirubin.total [Moles/volume] in Blood

157

645

2.45

24.10

2.2

2.3

24.51

29.46

umol/l

0.16

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

242

1204

2.02

23.27

1.3

1.5

—

(3006270) Folate [Moles/volume] in Blood

221

1068

2.08

23.00

1.2

1.1

402.98

384.67

nmol/l

0.64

178

966

(40760888) Immunoglobulin light chains.free panel - Serum

402

2359

1.72

22.96

1.8

3.5

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

315

1722

1.84

22.90

1.1

96.18

95.03

0.30

294

1619

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

166

717

2.33

22.81

1.4

1.5

20.10

21.92

u/ml

0.16

154

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2953

24669

1.24

22.67

2.2

2.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2676

22122

1.25

22.61

2.1

2.0

—

(40768804) Tissue Pathology biopsy report

6774

61186

1.17

22.08

2.1

2.0

—

(3027315) Oxygen [Partial pressure] in Blood

439

2671

1.66

21.92

4.9

3.4

8.78

8.80

kpa

0.05

428

2619

(3012501) Base excess in Blood by calculation

436

2649

1.66

21.89

4.9

3.4

3.07

2.30

mmol/l

5.78

308

1736

(3013290) Carbon dioxide [Partial pressure] in Blood

436

2650

1.66

21.86

4.9

3.4

5.22

4.96

kpa

9.10

425

2599

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

158

3.93

21.68

13.5

9.4

5.51

5.35

mmol/l

0.16

158

(40767503) Oxygen content in Capillary blood by calculation

401

2397

1.69

21.43

3.0

2.3

16.63

16.66

0.05

240

1163

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

222

1104

2.02

21.42

1.1

301.09

291.67

mg/l

1.01

191

1012

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

196

932

2.12

21.33

12.5

12.3

788.44

829.09

nmol/l

0.56

188

904

(3017732) Neutrophils [#/volume] in Blood

1359

10386

1.33

21.20

2.9

2.6

5.26

4.58

e9/l

1.03

1150

8745

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

267

1421

1.89

21.15

1.2

58.07

60.89

u/l

0.37

249

1272

(3024891) Influenza virus A+B Ag [Presence] in Specimen

607

4022

1.53

21.12

1.2

1.1

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

201

976

2.07

20.71

18.9

17.2

1449.17

2397.95

nmol/l

0.48

193

941

(3000034) Microalbumin [Mass/volume] in Urine

218

1094

2.00

20.53

3.8

2.8

79.93

59.14

mg/l

0.44

161

774

(3023511) Choriogonadotropin [Units/volume] in Urine

680

4646

1.48

20.42

1.4

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

330

1897

1.75

20.34

1.1

1.49

g/l

0.16

293

1732

(3040151) Glucose [Moles/volume] in Capillary blood

242

1270

1.92

20.03

12.9

9.5

8.34

7.11

mmol/l

1.27

193

1056

(3027570) Oxalate [Moles/time] in 24 hour Urine

5.13

19.98

2.2

1.4

355.02

319.49

umol/24h

0.47

(3002079) Sodium [Moles/time] in 24 hour Urine

149

653

2.29

19.87

1.3

1.2

176.44

153.26

mmol/24h

2.44

149

653

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1152

8708

1.35

19.33

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

397

2433

1.65

19.32

1.5

1.6

0.71

g/l

0.03

323

1844

(3051611) Lipemic interference index of Serum or Plasma

243

1293

1.89

19.30

3.4

3.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

271

1497

1.82

19.13

1.4

9.60

7.66

mmol/l

9.43

260

1453

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

166

775

2.15

19.00

1.2

18.46

21.02

u/l

0.48

149

661

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

169

796

2.13

18.91

1.2

79.75

85.61

u/l

0.52

157

693

(3037756) Immunofixation for Serum or Plasma

348

2079

1.69

18.70

1.3

1.7

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

141

624

2.27

18.41

1.1

1.3

74.29

60.65

titre

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

339

2023

1.69

18.30

1.5

1.8

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

390

2417

1.63

18.18

1.2

176.00

180.43

titre

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

139

616

2.27

18.10

1.2

1.1

3.00

3.44

iu/ml

—

(3011648) Oxygen content in Venous blood

189

948

2.00

17.89

2.5

2.6

11.97

11.09

2.10

189

948

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

211

1101

1.93

17.82

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

214

1122

1.92

17.82

1.4

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

298

1731

1.73

17.77

1.5

1.6

30.29

32.55

iu/ml

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

109

441

2.48

17.44

2.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

741

5303

1.41

17.41

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

199

1028

1.95

17.33

3.1

2.2

—

(3003338) MCHC [Mass/volume]

13758

132328

1.18

17.19

25.2

14.8

329.52

332.72

g/l

290.96

13667

131392

(40768443) Skin Pathology biopsy report

816

5959

1.39

17.04

1.2

—

(3045414) Leukocytes [Presence] in Urine

870

6428

1.37

16.91

1.9

1.8

—

(3022689) Creatine [Moles/volume] in Urine

343

2.66

16.84

1.5

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

198

1032

1.93

16.81

1.4

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

198

1032

1.93

16.81

1.4

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

198

1032

1.93

16.81

1.4

1.8

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1849

15141

1.25

16.67

2.0

1.9

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

808

5939

1.38

16.22

1.6

1.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.53

16.05

1.6

1.9

42.05

45.25

umol/l

0.31

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

288

1706

1.70

16.04

1.2

1.3

—

nmol/l

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

437

2873

1.53

15.86

1.5

1.6

—

(3021440) Promyelocytes/100 leukocytes in Blood

1360

10816

1.28

15.69

4.5

4.2

0.09

0.12

0.79

445

3024

(3017181) Myelocytes/100 leukocytes in Blood

1417

11327

1.27

15.69

4.5

4.1

0.93

0.00

502

3519

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

288

2.75

15.63

1.2

295.05

326.74

pmol/l

0.31

223

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

208

1131

1.85

15.55

1.5

25.11

34.51

3.61

139

691

(3019420) Tryptase [Mass/volume] in Serum or Plasma

170

866

1.97

15.48

1.4

1.5

6.79

7.48

ug/l

0.37

153

778

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

167

852

1.97

15.15

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

117

521

2.25

15.15

1.0

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

340

2.57

15.03

1.5

1.2

67.22

126.70

nmol/l

7.45

256

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

423

2798

1.52

14.95

1.5

1.7

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1390

17190

0.79

14.95

1.8

1.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

219

1229

1.79

14.80

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

867

6544

1.34

14.69

1.2

1.3

0.67

1.12

u/ml

0.87

556

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

127

3.63

14.47

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

110

487

2.27

14.46

1.1

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

113

506

2.24

14.46

1.7

1.4

—

(4062490) Immunoglobulin typing, IgG

262

1559

1.69

14.41

1.5

1.4

—

(3004775) Volume in Urine collected for unspecified duration

161

826

1.96

14.40

2.4

2.3

711.04

643.42

0.84

109

596

(3014271) Vancomycin [Susceptibility]

414

2.37

14.36

3.2

2.8

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

343

2.51

14.27

2.4

1.8

5690.29

14912.12

e6/l

0.70

168

(3026692) Albumin [Mass/volume] in Peritoneal fluid

263

2.74

14.23

1.6

1.4

14.12

13.02

g/l

0.46

193

(3002331) Protein [Mass/volume] in Peritoneal fluid

226

2.88

14.08

1.3

1.4

29.66

25.42

g/l

1.12

167

(3051651) Icteric interference index of Serum or Plasma

153

780

1.97

13.95

3.7

3.5

—

(3027035) Albumin [Mass/time] in 24 hour Urine

108

3.80

13.81

1.4

1.2

447.00

349.46

mg/24h

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

467

6687

0.69

13.74

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

467

6684

0.69

13.71

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

464

6642

0.69

13.63

1.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

388

2.38

13.56

2.5

2.1

484.94

2959.06

e6/l

0.62

256

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

494

3443

1.45

13.50

3.2

3.4

1.72

1.39

mg/l

11.42

453

3206

(3003327) Ova and parasites identified in Stool by Light microscopy

752

5639

1.35

13.33

1.7

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1288

10377

1.26

13.32

3.9

4.0

0.53

0.69

2.29

446

3073

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

469

6669

0.70

13.28

1.4

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

108

497

2.18

12.98

1.9

2.3

0.67

1.26

ug/l

3.76

472

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

439

6289

0.69

12.96

2.1

1.9

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

255

1551

1.65

12.95

1.5

1.4

2.85

2.98

g/l

0.60

200

1076

(3027135) IgG subclass 1 [Mass/volume] in Serum

255

1553

1.65

12.89

1.5

1.4

6.42

6.75

g/l

0.84

195

1081

(3010144) Erythrocytes [#/volume] in Synovial fluid

197

1119

1.77

12.85

1.4

83285.72

96850.46

e6/l

0.15

149

770

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1443

11824

1.24

12.84

1.9

1.8

—

(3044927) Protein electrophoresis panel - Urine

177

975

1.82

12.79

1.3

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

315

2025

1.57

12.74

1.5

1.7

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

158

841

1.89

12.73

1.0

1.1

2.96

6.97

nmol/l

0.82

167

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

315

2026

1.56

12.71

1.5

1.7

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

254

1552

1.65

12.68

1.5

1.4

0.43

0.39

g/l

0.32

198

1078

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

280

1753

1.61

12.68

2.4

2.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

461

3214

1.45

12.61

1.5

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

862

6654

1.31

12.51

1.4

1.3

192.32

233.90

miu/ml

2.92

374

3292

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

249

1520

1.65

12.49

1.6

59.46

52.73

1.69

159

953

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

457

3188

1.44

12.47

1.4

11.32

21.44

u/ml

—

(3001556) Androgen free Index in Serum or Plasma

172

3.03

12.35

1.5

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

182

1023

1.79

12.32

3.1

3.9

—

(3036180) Methadone [Presence] in Urine

147

773

1.91

12.30

1.7

2.6

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

923

11719

0.78

12.30

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

431

2984

1.46

12.25

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

515

7096

0.72

12.14

1.4

1.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

104

485

2.15

12.13

2.5

1.9

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

346

2.38

12.12

1.3

56.65

49.70

0.87

300

(21494890) Protein electrophoresis panel - 24 hour Urine

185

1051

1.77

12.09

1.4

2.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

427

2960

1.45

12.06

1.5

1.4

108.43

111.35

u/ml

0.25

672

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

161

884

1.83

11.80

2.1

2.0

100.28

97.75

0.45

152

803

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

107

511

2.10

11.75

3.1

2.8

—

(3025159) Blasts/100 leukocytes in Blood

1269

10361

1.24

11.66

4.6

4.2

0.13

0.39

1.52

363

2590

(3020491) Glucose [Moles/volume] in Blood

181

1034

1.76

11.63

2.1

1.7

7.26

6.30

mmol/l

2.96

117

767

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

236

1449

1.64

11.61

2.7

1.9

27.43

23.92

mg/l

0.48

363

(3006922) Hepatitis E virus Ab [Presence] in Serum

187

1080

1.74

11.57

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

187

1083

1.73

11.46

3.4

2.8

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

252

1578

1.61

11.45

1.6

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

202

1199

1.69

11.33

1.5

1.8

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

216

1327

1.64

10.64

1.5

1.8

—

(3032057) Clostridioides difficile [Presence] in Stool

240

2.55

10.53

2.0

1.9

—

(3000093) Morphology [Interpretation] in Blood Narrative

185

1099

1.69

10.39

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

136

739

1.85

10.37

1.5

1.2

275.58

329.53

u/l

0.30

129

682

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

427

3049

1.41

10.32

1.2

1.3

272.54

266.15

u/ml

0.18

266

2013

(3025468) Yersinia sp identified in Specimen by Organism specific culture

260

1684

1.55

10.28

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

307

2061

1.50

10.27

1.2

1.4

—

(37021550) Renin [Units/volume] in Plasma --upright

274

2.41

10.18

1.3

85.35

63.21

mu/l

0.37

212

(3005988) Vibrio sp identified in Specimen by Organism specific culture

260

1688

1.55

10.17

1.5

—

(3033799) Differential panel - Peritoneal fluid

337

2.26

10.10

2.7

1.9

—

(3045424) Erythrocytes [Presence] in Urine

344

2373

1.46

10.05

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

427

3066

1.40

10.01

1.6

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

259

1687

1.54

9.99

1.5

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

142

792

1.80

9.97

1.7

145.35

133.22

1.16

136

738

(3028271) Lactate [Moles/volume] in Capillary blood

278

1842

1.52

9.92

2.2

1.7

1.79

1.67

mmol/l

1.37

270

1805

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

447

3245

1.39

9.83

1.2

—

(3008898) HLA-B27 [Presence]

812

6427

1.28

9.78

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

408

5628

0.72

9.75

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

397

5487

0.72

9.61

1.4

1.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

220

1394

1.59

9.60

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

220

1395

1.58

9.57

1.5

—

(3022806) Fractional oxyhemoglobin in Capillary blood

236

1524

1.56

9.49

2.1

1.7

89.42

90.49

2.02

230

1504

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

236

1524

1.56

9.49

1.4

—

(3019977) pH of Arterial blood

110

576

1.92

9.44

2.8

2.5

7.42

7.43

0.95

179

(43055442) Apixaban [Mass/volume] in Serum or Plasma

108

3.24

9.40

1.5

97.43

116.46

ug/l

0.56

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

130

720

1.81

9.37

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

258

1706

1.52

9.32

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

258

1706

1.52

9.32

1.5

—

(3044007) Cell count panel - Peritoneal fluid

317

2.24

9.32

2.2

1.9

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

262

1739

1.51

9.30

1.5

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

226

2.48

9.22

1.1

1.0

0.41

0.11

u/ml

0.52

139

(3005033) Fetal Nuchal fold Thickness US

400

5481

0.72

9.19

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

283

1914

1.49

9.18

2.7

3.2

1.12

1.51

1.68

254

1730

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

100

513

1.95

9.14

1.3

1.5

13.34

14.76

pmol/l

1.55

434

(3023419) Bacteria identified in Sputum by Culture

249

1644

1.52

9.08

2.6

2.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

445

3275

1.37

9.03

1.2

1.3

3.85

3.66

mmol/l

3.30

416

3079

(3008116) Ketones [Moles/volume] in Urine by Test strip

256

2.35

8.77

1.3

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

478

3576

1.35

8.74

2.5

2.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

126

707

1.79

8.73

1.4

—

(3023410) Appearance of Cerebral spinal fluid

232

1525

1.53

8.66

1.4

1.6

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

438

3239

1.36

8.64

1.2

1.3

4.67

3.72

u/ml

0.13

269

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

339

2404

1.42

8.60

1.4

1.3

7.39

6.88

mmol/l

2.89

303

2175

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

309

2.21

8.59

1.3

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

110

596

1.85

8.55

1.1

1.2

0.33

0.30

g/l

3.61

476

(3007461) Platelets [#/volume] in Blood

16951

167607

1.25

8.40

29.4

17.3

266.64

257.89

e9/l

58.58

16695

163993

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

609

4744

1.29

8.37

1.6

2.77

5.89

iu/ml

0.31

130

969

(40768793) Breast Pathology biopsy report

259

3759

0.68

8.35

1.2

1.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

291

2019

1.45

8.33

1.3

42.15

58.41

u/ml

0.52

148

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

250

2.32

8.31

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

129

2177

0.59

8.28

1.5

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

304

2131

1.43

8.24

1.5

1.4

—

(3024263) Appearance of Synovial fluid

116

647

1.80

8.23

1.3

1.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

163

999

1.64

8.23

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

162

993

1.64

8.18

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

16932

167437

1.24

8.11

29.6

17.3

40.44

40.43

0.03

16362

158591

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

4.53

8.10

2.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

135

2.82

8.08

9.7

7.6

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

102

551

1.86

8.04

1.1

1.2

113.47

110.86

0.56

503

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

263

1805

1.46

7.99

1.4

—

(3022621) pH of Urine by Test strip

1074

8970

1.21

7.96

3.3

2.7

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

322

2308

1.40

7.74

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

101

553

1.83

7.65

1.4

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

101

553

1.83

7.65

1.4

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

881

7244

1.23

7.64

1.4

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

497

1.88

7.60

2.9

2.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

574

4496

1.29

7.60

1.3

25.57

33.13

u/ml

0.27

309

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

141

851

1.66

7.60

1.6

5.62

6.71

u/l

0.60

116

697

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

104

577

1.81

7.55

1.1

114.60

110.02

0.62

510

(3049717) Cytology report of Urine Cyto stain

489

3754

1.31

7.54

2.2

2.5

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

627

4971

1.27

7.53

1.6

1.9

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

141

2.70

7.47

1.0

1.2

39.27

43.03

mg/l

0.63

(3035941) MCH [Entitic mass]

16952

167745

1.23

7.47

29.2

17.2

29.68

30.23

275.83

16828

165898

(3016750) Collection duration of Urine

109

616

1.77

7.45

2.1

2.2

509.70

499.65

min

0.55

491

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

436

3300

1.33

7.44

1.4

1128.23

2474.09

e6/l

0.52

345

2699

(3024731) MCV [Entitic volume]

16953

167767

1.23

7.39

29.2

17.2

89.90

90.64

79.25

16829

165916

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

301

2151

1.41

7.38

2.2

2.8

217.29

1941.68

u/ml

—

106

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

485

3731

1.31

7.37

1.3

449.58

487.50

mg/l

1.31

468

3565

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

435

3296

1.33

7.37

1.3

1.4

41.52

23.76

e6/l

0.26

328

2565

(3026361) Erythrocytes [#/volume] in Blood

16953

167783

1.23

7.27

29.4

17.3

4.57

4.50

e12/l

62.43

16665

163839

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

419

3165

1.33

7.26

1.2

5.61

19.69

u/ml

—

(3010813) Leukocytes [#/volume] in Blood

16954

167804

1.22

7.20

29.4

17.3

7.40

6.60

e9/l

307.65

16660

163803

(4094501) Cardiovascular stress test using bicycle ergometer

476

3667

1.31

7.17

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

456

3494

1.31

7.15

1.2

1.3

26.34

40.41

u/ml

1.18

359

(3006576) Bicarbonate [Moles/volume] in Blood

381

1.97

7.15

6.2

5.8

25.25

24.93

mmol/l

0.22

359

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

101

567

1.79

7.08

1.1

96.57

92.21

0.92

252

(3003181) Sodium [Moles/volume] in Urine

264

1858

1.43

7.08

1.3

1.4

64.85

63.83

mmol/l

0.13

202

1486

(3020961) Endomysium IgA Ab [Titer] in Serum

971

8129

1.21

7.05

1.1

94.38

208.10

titre

2.02

213

(3000963) Hemoglobin [Mass/volume] in Blood

16955

167843

1.22

7.01

29.5

17.4

134.55

135.45

g/l

13.83

16839

165992

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

6.96

6.98

4.9

6.6

0.20

0.14

mmol/l

0.71

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

205

2999

0.68

6.97

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

164

2.50

6.97

5.9

5.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

430

3284

1.32

6.92

1.1

3.40

5.33

u/ml

3.18

243

1681

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

170

1101

1.55

6.89

1.2

1.4

12.43

11.23

umol/l

1.45

154

1053

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

3.34

6.81

1.0

0.40

0.09

u/ml

0.74

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

524

4121

1.28

6.77

1.3

7.08

7.98

u/ml

0.16

692

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

373

2804

1.34

6.71

4.5

5.7

15146.34

1670.69

iu/ml

0.45

396

(3016018) Differential panel - Cerebral spinal fluid

231

1603

1.45

6.71

1.3

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

381

2878

1.33

6.64

2.4

2.2

6.04

6.42

umol/l

0.22

268

2092

(3012565) Volume of 24 hour Urine

103

594

1.74

6.62

2.0

2.2

1861.94

2033.74

0.90

542

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

524

4136

1.27

6.58

1.8

2.0

3.25

12.95

iu/l

1.15

188

1655

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

151

964

1.57

6.54

1.5

1.4

5.79

5.46

mmol/l

3.14

140

915

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

474

3702

1.29

6.48

2.3

2.7

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

172

1135

1.52

6.44

1.2

1.3

0.97

1.48

u/ml

0.43

617

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

213

1469

1.46

6.41

2.8

3.2

5.34

9.19

nmol/l

0.50

195

1427

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

576

7145

0.80

6.39

1.5

1.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

528

1.77

6.33

8.6

4.7

2033.76

2582.81

mg/l

0.10

386

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

324

2417

1.35

6.18

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

234

1657

1.42

6.13

1.5

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

556

1.73

6.11

1.1

101.19

93.67

1.29

254

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

149

966

1.55

6.07

1.5

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

510

4055

1.27

6.07

1.3

7.03

6.07

u/ml

0.09

450

(3008401) Mugwort IgE Ab [Units/volume] in Serum

404

3127

1.30

5.96

1.1

0.52

1.14

u/ml

3.40

189

1293

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

101

2.77

5.87

1.5

1.3

1.16

2.00

ml/s/173m2

0.48

(3041096) Erythrocytes [Presence] in Urine by Automated

4334

40502

1.09

5.83

3.7

2.9

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

156

1033

1.51

5.79

1.1

1.06

ratio

0.01

382

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

245

2.08

5.74

1.1

1.4

0.22

0.32

nmol/l

0.95

165

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

3.23

5.71

1.0

0.19

0.07

u/ml

0.43

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

406

1.83

5.68

1.5

1.6

10.49

8.42

ug/l

2.89

406

(40768800) Prostate Pathology biopsy report

116

1822

0.63

5.67

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

460

3649

1.27

5.61

1.1

1.24

2.00

u/ml

1.60

256

1782

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

133

862

1.55

5.47

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

130

840

1.55

5.43

1.4

1.3

500.14

392.08

u/l

0.83

122

803

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

316

2398

1.32

5.42

1.6

1.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

431

3408

1.27

5.42

1.5

1.4

0.44

0.43

nmol/l

0.07

357

2665

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.54

5.31

1.1

1.4

702.21

549.09

nmol/l

0.40

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1239

10859

1.15

5.22

2.3

20.67

21.70

au/ml

0.12

1002

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

195

2.16

5.19

6.8

6.3

64.58

71.12

0.67

153

(40761536) Microorganisms panel - Urine sediment

1408

12465

1.14

5.13

4.2

3.5

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

117

749

1.57

5.12

1.1

96.88

94.10

0.41

616

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

210

2.10

5.08

3.0

2.1

7.92

7.66

mmol/l

0.13

120

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

186

1312

1.42

5.06

1.6

—

(3044290) Cell count panel - Cerebral spinal fluid

390

3074

1.27

5.06

1.3

1.4

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

147

2.32

4.98

4.7

2.6

1.59

1.10

mmol/l

0.38

105

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

192

2.14

4.97

1.2

1.6

554549.87

388826.93

nmol/l

0.15

161

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

157

1079

1.46

4.93

1.1

7.57

7.88

iu/ml

0.07

300

(3036312) Salmon IgE Ab [Units/volume] in Serum

2.63

4.80

1.0

1.1

0.00

0.87

u/ml

1.23

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1137

9971

1.15

4.77

1.2

1.3

35.24

50.32

au/ml

1.20

523

(3043410) Blood group antigens tested for on Red Blood Cells

349

1.81

4.76

1.9

1.7

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

115

747

1.54

4.75

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

158

1096

1.45

4.74

1.7

1.5

4544.37

2647.75

e6/l

0.34

112

789

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

170

2.18

4.72

2.4

2.7

71.95

58.93

pmol/l

0.16

144

(3013247) Albumin in CSF/Albumin in Serum or Plasma

387

1.76

4.70

1.0

1.1

6.48

6.32

mg/g

0.10

362

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

111

719

1.55

4.65

1.4

1.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

144

993

1.45

4.48

1.7

1.4

59526.55

43590.66

e6/l

0.35

584

(3010375) cycloSPORINE [Mass/volume] in Blood

616

1.58

4.45

26.4

27.1

122.40

115.90

ug/l

0.32

508

(3026389) Candida sp identified in Specimen by Organism specific culture

292

2260

1.30

4.43

1.5

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1046

9174

1.15

4.41

2.4

3.1

38.83

44.96

u/ml

0.54

1000

8862

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

168

1200

1.40

4.33

1.9

1.7

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

144

1002

1.44

4.29

1.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

482

1.64

4.28

1.1

1.31

3.42

u/ml

0.57

270

(3008757) Leukocyte morphology finding [Identifier] in Blood

177

1279

1.39

4.27

2.3

3.8

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

527

4382

1.21

4.26

1.2

—

(3042733) HLA Ab [Presence] in Serum

469

1.64

4.21

5.0

5.1

—

(3025577) Chromium [Mass/volume] in Blood

570

1.58

4.20

1.9

2.1

2.08

2.46

ug/l

0.54

485

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

102

2.45

4.20

1.9

2.1

—

(3002619) Bacteria identified in Specimen by Culture

276

1.85

4.20

1.3

1.2

—

(3004451) EKG impression Narrative

502

1.62

4.14

1.3

1.2

—

(3026470) Cobalt [Mass/volume] in Blood

588

1.57

4.14

1.9

2.0

3.95

3.51

ug/l

0.22

536

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

129

886

1.46

4.13

1.4

7.22

5.73

u/l

0.60

107

755

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

147

2.18

4.13

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

135

2.22

4.07

1.1

1.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

176

1282

1.38

4.07

1.2

—

(4281824) Cell count and differential, peritoneal fluid

216

1625

1.33

4.05

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

137

956

1.44

4.05

2.1

1.9

2.43

2.08

u/field

0.26

431

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

176

1283

1.38

4.05

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

569

4791

1.19

4.04

1.4

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

530

1.59

4.00

1.4

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

530

1.59

4.00

1.4

1.5

—

(3042517) Benzodiazepines panel - Urine

224

1.92

3.99

2.7

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

340

1.74

3.97

3.5

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

340

1.74

3.97

3.5

2.4

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

175

1281

1.37

3.94

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

177

1299

1.37

3.92

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

589

1.55

3.90

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.63

3.88

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

169

1234

1.37

3.87

1.7

1.4

34.64

33.70

g/l

0.46

155

1120

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

135

949

1.43

3.85

2.2

1.6

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

176

1297

1.36

3.81

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

176

1297

1.36

3.81

1.2

—

(3006462) Nitrate [Presence] in Urine

100

665

1.51

3.79

3.2

2.9

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

657

1.51

3.79

1.4

1.3

13.42

13.49

u/l

0.01

607

(3020191) Ethanol [Moles/volume] in Serum or Plasma

163

1189

1.37

3.77

1.6

1.4

1.13

1.36

promille

1.34

129

903

(3016330) Potassium [Moles/time] in 24 hour Urine

208

1.93

3.75

1.2

—

87.33

—

(3036670) Protein [Mass/volume] in Synovial fluid

317

1.74

3.72

1.3

1.2

36.77

39.33

g/l

0.65

164

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

273

1.80

3.72

1.3

1.6

—

(3005011) Chlamydia sp Ab [Titer] in Serum

231

1.86

3.66

1.6

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

203

1.92

3.65

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2099

19370

1.09

3.65

1.5

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

639

1.50

3.64

1.4

2.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

372

1.67

3.64

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

261

1.80

3.61

1.1

0.77

0.89

umol/24h

0.21

140

(3025886) Oxalate [Mass/time] in 24 hour Urine

3.72

3.58

1.5

1.1

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

2.35

3.56

3.6

1.6

66.20

59.73

0.33

(3025018) Bordetella pertussis Ab [Titer] in Serum

137

981

1.40

3.56

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

504

4254

1.19

3.53

2.9

3.6

458.25

1738.24

u/ml

1.15

421

3661

(3016038) Potassium [Moles/volume] in Urine

104

709

1.47

3.53

1.1

1.2

32.56

35.31

mmol/l

0.61

620

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

125

883

1.42

3.51

1.5

1.4

—

(3034426) Prothrombin time (PT)

565

1.52

3.49

1.3

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

102

695

1.47

3.47

1.7

2.10

2.52

u/field

0.29

503

(3034891) Synovial lining cells/100 cells in Synovial fluid

599

1.50

3.44

1.5

4.85

3.47

0.27

137

(3047189) Immunofixation for 24 hour Urine

472

1.57

3.43

1.3

1.9

—

(3036782) Glucose [Moles/volume] in Pleural fluid

130

930

1.40

3.41

1.4

1.3

6.73

6.26

mmol/l

1.01

118

861

(3047181) Lactate [Moles/volume] in Blood

459

3856

1.20

3.41

7.9

5.3

1.41

1.26

mmol/l

2.93

418

3397

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

641

1.48

3.40

1.4

2.1

—

(3008295) Osmolality of Serum or Plasma

164

1220

1.35

3.39

1.5

283.92

279.85

mosm/kgh2o

1.30

113

965

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

761

0.58

3.37

1.0

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

111

776

1.43

3.32

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

203

2616

0.77

3.31

3.1

3.6

26.09

34.86

u/ml

0.57

198

2529

(3045788) Cell count panel - Pleural fluid

121

861

1.41

3.29

1.7

1.5

—

(3018133) Calcium [Moles/volume] in Urine

211

1.85

3.29

1.4

1.8

2.80

2.65

mmol/l

0.14

188

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

525

1.53

3.28

3.3

—

(44813793) Dust mix specific IgE antibody measurement

159

1184

1.35

3.28

1.0

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

307

1.70

3.28

1.3

38.77

41.56

0.18

211

(40768446) Kidney Pathology biopsy report

534

1.52

3.26

1.5

1.7

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

510

1.53

3.26

1.4

2.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

777

0.59

3.24

1.5

—

(3000012) Reticulocyte production index

191

1464

1.31

3.23

2.2

2.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

101

698

1.45

3.23

1.1

17.93

23.03

u/l

1.00

639

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

288

1.70

3.15

1.2

—

(3012441) Differential panel - Pleural fluid

131

953

1.38

3.15

1.6

1.5

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

334

1.65

3.14

1.1

1.0

1.32

1.44

u/ml

0.04

279

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

500

1.52

3.10

1.4

2.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

500

1.52

3.10

1.4

2.3

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

486

4149

1.18

3.04

1.5

1.4

107.20

114.21

pmol/l

0.16

466

4048

(3051593) INR in Capillary blood by Coagulation assay

431

1.56

3.03

16.6

9.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

300

2455

1.23

2.97

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

120

2.08

2.97

1.2

1.1

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

2.40

2.96

3.5

1.5

18.10

19.97

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

157

1190

1.32

2.92

2.7

3.2

58.77

56.14

0.99

140

1020

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

614

1.45

2.91

2.7

2.5

53.43

50.62

umol/l

0.30

540

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.44

2.89

2.4

2.1

1.88

2.26

mu/l

0.16

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

170

1308

1.30

2.85

1.4

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

1212

0.70

2.77

1.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

270

2210

1.23

2.71

1.1

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

196

1.79

2.70

1.0

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

6.00

2.69

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

150

1145

1.31

2.69

1.6

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

288

1.63

2.64

1.4

1.6

0.45

0.40

ug/l

0.44

191

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

133

1.96

2.64

2.0

1.9

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

351

1.57

2.63

1.1

71.33

71.54

—

(3029075) Extractable nuclear Ab panel - Serum

455

1.50

2.62

1.2

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

497

1.47

2.59

2.4

2.9

30.41

27.99

umol/l

0.65

382

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

145

1108

1.31

2.59

1.3

1.2

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

208

1665

1.25

2.58

1.0

1.1

—

63.25

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

353

1.56

2.57

1.1

107.25

83.82

—

102

(3002621) Streptococcal DNAse B [Units/volume] in Serum

114

2.02

2.55

1.0

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2296

24389

0.93

2.52

3.7

3.9

21.79

21.66

0.12

808

11032

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

2.16

2.50

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

145

1115

1.30

2.49

1.3

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

686

1.39

2.47

1.5

1.4

—

(3039000) Anion gap in Blood

312

2618

1.20

2.46

9.7

6.4

11.66

11.19

mmol/l

1.63

287

2344

(3018572) Chloride [Moles/volume] in Blood

312

2619

1.19

2.45

9.7

6.4

105.14

105.32

mmol/l

0.33

287

2345

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3152

33090

0.94

2.40

1.5

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

189

1.75

2.40

1.0

1.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

465

1.46

2.39

1.9

2.1

60.74

61.87

ug/l

0.06

453

(21491868) Cryoglobulin [Mass/volume] in Serum

524

1.43

2.36

1.1

1.2

—

0.24

g/l

—

(40762814) Titanium [Mass/volume] in Blood

146

1.85

2.36

2.0

2.3

3.00

4.03

ug/l

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

282

1.60

2.35

7.0

7.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

2271

21408

1.07

2.34

1.8

1.7

—

(3029612) Listeria sp Ab [Titer] in Serum

2.82

2.34

1.2

1.5

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

175

1397

1.26

2.27

2.0

2.1

31.35

32.85

3.79

175

1387

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.22

2.27

1.1

1.3

170.44

113.37

ug/l

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

327

1.53

2.20

1.6

1.8

53.00

28.81

u/l

0.36

295

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

178

1430

1.25

2.19

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

101

757

1.34

2.13

1.1

4.49

10.38

u/ml

2.53

125

(3001729) Color of Synovial fluid

2.05

2.10

1.1

1.5

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

5.00

2.07

1.0

1.1

—

(40768806) Pleura Pathology biopsy report

128

997

1.29

2.06

1.7

1.5

—

(40765089) Chromosome analysis panel - Blood by G-banded

557

0.63

2.06

1.0

—

(3000060) B lymphocytes [#/volume] in Blood

449

1.43

2.02

1.8

2.4

143.66

215.88

e6/l

0.70

238

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

618

1.36

2.02

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

360

3121

1.16

1.98

1.1

1.69

1.81

u/ml

0.09

208

1518

(3048879) Bone marrow aspiration report

296

1.52

1.96

1.2

2.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1309

12184

1.08

1.95

1.5

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

202

1.63

1.94

1.0

0.01

0.15

u/ml

1.53

115

(3051387) C reactive protein [Mass/volume] in Capillary blood

322

2774

1.16

1.93

4.9

3.0

24.29

25.22

mg/l

0.17

189

1705

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

549

1.37

1.88

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1185

11009

1.08

1.87

1.7

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

253

1.54

1.83

1.4

1.2

18.71

188.32

ug/l

2.71

137

(3027540) Rickettsia typhi Ab [Titer] in Serum

3.04

1.79

1.0

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

175

1440

1.22

1.79

1.1

1.2

41.27

39.20

mg/l

0.31

155

1207

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

166

1359

1.22

1.79

1.1

—

(3035880) pH of Pleural fluid

504

1.37

1.77

1.2

1.3

—

(3050794) Legionella sp Ab [Presence] in Serum

109

1.84

1.76

1.3

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

208

1.59

1.75

1.4

1.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

216

1.58

1.75

1.1

1.5

86.48

70.50

ng/l

0.19

132

(3038177) Helicobacter pylori Ab [Presence] in Serum

330

2874

1.15

1.75

1.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

139

1.73

1.75

1.3

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

537

4830

1.12

1.71

1.1

4.36

5.55

u/ml

0.35

724

(3028433) Virus identified in Specimen by Culture

465

1.38

1.71

1.3

1.2

—

(3024932) HLA-DR beta [Type]

467

1.37

1.67

1.1

—

(3017704) Immunofixation for Urine

545

1.34

1.65

1.2

1.7

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

968

0.75

1.65

1.1

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.89

1.64

1.2

—

(3024471) HLA-A [Type]

477

1.36

1.64

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

147

1784

0.82

1.59

1.7

1.6

8.83

7.54

mmol/l

8.18

138

1722

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

636

1.31

1.59

1.2

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

320

1.44

1.58

1.1

—

(3013466) aPTT in Blood by Coagulation assay

106

1.79

1.58

1.2

1.1

35.26

36.53

0.78

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

498

1.35

1.58

1.2

1.3

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.20

1.56

1.1

270.55

252.04

nmol/l

0.09

(3016031) Almond IgE Ab [Units/volume] in Serum

114

1.76

1.56

1.1

1.0

0.08

0.51

u/ml

1.49

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.27

1.55

1.0

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

168

1401

1.20

1.55

1.1

227.39

241.66

mg/l

0.72

154

1225

(3004446) Plasmodium sp identified in Blood by Light microscopy

169

1.60

1.51

2.4

2.5

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

241

1.49

1.51

1.1

1.2

26.80

104.71

titre

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.86

1.50

1.0

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.86

1.50

1.6

1.2

22.14

21.15

mmol/l

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

250

1.48

1.49

2.4

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

226

1.51

1.48

1.6

1.8

50.98

48.64

pmol/l

0.06

193

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

183

1546

1.19

1.48

1.0

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

259

1.47

6.9

7.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

128

1046

1.23

1.46

1.8

2.2

—

(3038026) Centromere Ab [Units/volume] in Serum

140

1155

1.21

1.46

1.2

41.92

44.62

u/ml

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

2.50

1.45

1.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.73

1.43

1.0

1.1

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.03

1.43

1.2

1.5

0.00

0.09

u/l

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.97

1.43

1.2

1.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

164

1.59

1.42

1.1

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

217

1868

1.16

1.41

1.2

1.3

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

111

1.71

1.38

1.0

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

1.77

1.38

1.5

1.4

23.36

36.52

0.59

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.94

1.38

1.0

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

152

1273

1.20

1.37

1.2

1.4

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

137

1137

1.21

1.36

1.2

82.17

44.25

u/ml

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

419

0.67

1.34

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

122

1004

1.22

1.33

1.8

1.4

75.98

77.66

umol/l

0.18

122

1004

(3011436) Histone Ab [Units/volume] in Serum

307

1.40

1.33

1.0

1.1

—

32.50

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.97

1.32

1.2

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

620

1.28

1.31

2.6

3.2

8.03

7.97

mg/l

0.03

489

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

2.50

1.30

1.0

1.2

1.53

1.50

mg/l

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

621

1.27

1.30

1.6

1.5

—

(3026250) Tacrolimus [Mass/volume] in Blood

639

1.27

1.29

36.1

35.2

7.24

7.39

ug/l

0.30

588

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

234

1.45

1.28

4.3

5.7

—

(36303858) Crystals [Presence] in Urine

2.78

1.28

1.2

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.08

1.27

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

283

2507

1.13

1.25

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

286

1.40

1.24

1.2

1.1

—

(40758292) HTLV I+II Ab panel - Serum

241

0.58

1.23

1.1

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1315

12470

1.06

1.22

3.2

4.0

35.07

22.06

ug/l

0.68

1022

9735

(3029634) Reagin Ab [Titer] in Serum by VDRL

256

2258

1.14

1.22

2.0

1.9

1.17

6.52

titre

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.96

1.22

5.7

9.4

—

(40768795) Lymph node Pathology biopsy report

113

1361

0.83

1.21

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

230

2017

1.14

1.20

2.4

2.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

862

0.79

1.18

1.6

2.0

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

445

1.30

1.17

1.8

1.6

133.69

139.08

au/ml

0.03

(3001964) Herpes simplex virus Ag [Presence] in Specimen

445

1.30

1.17

1.4

1.5

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.70

1.17

1.4

—

(3044336) Cobalt [Moles/volume] in Urine

0.00

1.16

0.0

2.6

—

28.09

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.81

1.14

1.1

1.0

—

(3017509) Phencyclidine [Presence] in Urine

207

1.45

1.14

1.8

1.7

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

109

904

1.21

1.14

1.2

1.3

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.68

1.13

1.2

1.1

12.88

10.36

mg/l

0.36

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

191

1.47

1.13

1.0

1.3

29.40

41.28

mg/l

1.38

160

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

635

1.25

1.12

1.6

1.5

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.90

1.12

1.1

1.3

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

267

1.39

1.11

1.2

50.73

80.13

mg/l

0.21

200

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

143

1.54

1.11

2.0

2.3

0.55

0.76

u/field

0.66

143

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

135

1.56

1.11

1.5

1.6

2.06

1.56

mg/l

0.32

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

135

1.56

1.11

1.5

1.6

0.94

2.00

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

135

1.56

1.11

1.5

1.6

1.34

2.47

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

135

1.56

1.11

1.5

1.6

2.67

4.33

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

135

1.56

1.11

1.5

1.6

2.04

1.77

mg/l

0.06

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

135

1.56

1.11

1.5

1.6

0.48

1.01

mg/l

0.89

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

135

1.56

1.11

1.5

1.6

0.65

2.53

mg/l

3.09

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

135

1.56

1.11

1.5

1.6

2.64

2.24

mg/l

0.15

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

135

1.56

1.11

1.5

1.6

1.12

1.08

mg/l

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

293

1.37

1.11

3.3

2.5

—

(3004616) Nuclear Ab [Presence] in Serum

212

1863

1.14

1.10

1.3

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

556

1.26

1.10

2.0

1.9

7.22

9.64

mg/l

3.22

449

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

189

1648

1.15

1.10

1.2

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

193

1.45

1.08

1.0

—

(3000285) Sodium [Moles/volume] in Blood

136

1.54

1.08

1.3

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.69

1.07

1.3

1.1

—

(3015183) Erythrocyte sedimentation rate

957

0.81

1.04

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

280

1.36

1.03

1.4

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

123

1044

1.18

1.03

2.3

2.7

559.99

512.93

e6/l

0.63

100

874

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

571

1.24

1.02

2.2

2.7

177.18

137.57

au/ml

0.27

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

179

1.45

1.02

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

589

1.24

1.02

1.1

—

(40757373) Influenza virus identified in Isolate

247

1.38

1.01

1.7

1.6

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.77

1.00

1.1

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

357

0.70

1.00

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

357

0.70

1.00

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

357

0.70

1.00

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

357

0.70

1.00

1.0

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.00

1.00

1.0

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

139

1.51

0.99

1.5

1.6

0.55

2.36

mg/l

3.02

(3011841) English Walnut IgE Ab [Units/volume] in Serum

172

1.45

0.99

1.0

0.01

0.88

u/ml

0.78

122

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

150

1727

0.87

0.98

1.5

—

(3017400) Magnesium [Moles/volume] in Urine

2.17

0.98

1.2

1.0

2.89

2.60

mmol/l

—

(1175426) CD3 cells/100 lymphocytes in Blood

132

1133

1.17

0.98

1.7

2.2

74.77

73.82

0.36

126

1086

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

811

1.20

0.97

1.1

1721.29

1487.52

miu/ml

1.04

811

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

802

1.20

0.97

1.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

318

1.32

0.97

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

838

0.81

0.97

1.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

649

0.79

0.96

2.8

3.0

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

116

1.55

0.96

1.1

20.67

23.99

u/l

0.37

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.65

0.94

1.0

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.61

0.93

1.1

10.20

11.12

u/l

0.06

(36304315) Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay

2.22

0.93

1.0

1.2

—

739.83

au/ml

—

(3045462) Protein/Creatinine [Ratio] in Urine

117

1.54

0.93

4.6

4.4

38.12

60.49

g/mol

0.68

106

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

257

0.66

0.92

1.1

1.0

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.82

0.92

1.0

0.01

0.07

u/ml

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.14

0.91

1.8

1.5

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.14

0.91

2.3

2.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

118

1.53

0.90

1.4

1.2

4.96

5.81

mmol/l

—

(3026726) Creatinine [Moles/volume] in Specimen

102

1.57

0.90

2.9

2.5

233.06

423.48

umol/l

0.55

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

177

1.41

0.88

1.0

0.21

2.20

u/ml

0.47

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

556

1.22

0.88

1.1

1.0

4.17

11.28

u/ml

4.72

333

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.79

0.87

1.1

1.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

113

969

1.17

0.87

1.1

1.03

1.05

u/l

0.31

405

(3045142) Bone marrow Pathology biopsy report

108

1260

0.86

0.87

1.2

1.3

—

(4212803) Bone marrow aspirate examination

103

1.55

0.87

1.1

—

(4035726) Immunohistochemistry procedure

1134

11860

0.95

0.86

1.3

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

153

1.44

0.85

1.0

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

118

1019

1.16

0.84

2.4

2.8

0.25

0.23

e9/l

0.35

101

872

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

180

1602

1.12

0.83

3.5

4.6

66.74

110.16

u/ml

0.84

511

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

101

863

1.17

0.83

1.9

1.6

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

243

2201

1.11

0.82

1.1

1.0

0.34

0.43

u/ml

0.23

570

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

125

1087

1.15

0.82

1.2

1.1

—

(3011412) CD3 cells [#/volume] in Blood

161

1426

1.13

0.81

2.1

2.6

1.44

1.22

e9/l

2.42

140

1267

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.61

0.81

1.0

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

375

0.75

0.80

3.8

2.8

79.67

108.88

ng/l

0.73

186

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

293

2683

1.09

0.80

1.1

24.08

10.60

au/ml

0.50

197

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.79

0.0

1.0

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

139

1.44

0.79

2.1

3.1

1.56

1.22

mg/l

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.67

0.78

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

684

1.18

0.78

1.1

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.52

0.78

1.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

547

1.21

0.77

2.2

2.4

152.24

153.23

nmol/l

0.03

475

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.77

0.0

5.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

394

1.24

0.76

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.64

0.75

2.8

2.3

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.08

0.74

1.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

149

1325

1.13

0.73

1.6

1.4

20.39

32.04

nmol/l

8.79

128

1218

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

325

1.26

0.72

1.1

—

(3006598) pH of Arterial cord blood

1.80

0.72

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

176

1.36

0.72

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

335

1.25

0.71

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

654

1.18

0.71

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

127

1124

1.13

0.68

1.0

0.62

1.76

u/ml

1.16

236

(3014891) Appearance of Pleural fluid

110

1.45

0.68

1.4

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

311

1.25

0.67

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

179

1.34

0.66

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

274

2530

1.08

0.66

1.1

3.79

4.67

u/ml

0.40

118

1048

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1714

17653

0.97

0.65

2.6

2.8

0.61

0.73

ug/l

2.98

1125

10974

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

679

1.16

0.65

6.1

49.07

5890.19

u/ml

0.67

136

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

180

1.33

0.64

1.2

1.6

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

120

1.42

0.64

1.4

1.2

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.72

0.64

1.0

1.3

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

207

1.30

0.63

1.2

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

844

8087

1.05

0.63

1.7

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3101

30381

1.03

0.62

4.1

4.5

1.63

2.74

ug/l

6.77

2740

27582

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

252

1.27

0.62

1.0

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.63

0.62

1.3

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.60

0.61

1.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

307

1.24

0.60

1.1

1.0

0.63

1.91

u/ml

0.59

214

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

389

1.21

0.60

1.1

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

722

1.15

0.60

1.6

2.1

201.36

197.83

u/l

0.25

716

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

174

1.32

0.59

1.0

0.10

0.14

u/ml

0.09

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

864

1.13

0.59

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

114

1.40

0.58

1.0

1.1

—

(3035060) Mercury [Moles/volume] in Blood

0.00

0.58

0.0

1.8

—

8.50

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.51

0.58

1.0

—

(3007733) Chloride [Moles/volume] in Urine

1.71

0.57

1.0

1.3

92.67

83.10

mmol/l

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

132

1.36

0.56

1.1

—

2.20

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

141

1.35

0.56

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.51

0.56

3.0

6.4

—

(46235168) Fasting glucose [Moles/volume] in Blood

172

0.70

0.56

1.7

1.2

7.62

7.06

mmol/l

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.56

0.55

1.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

690

1.15

0.55

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.62

0.55

1.0

1.2

—

mmol/l

—

(3022670) pH of Venous cord blood

1.62

0.55

1.2

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

222

1.26

0.53

1.3

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

267

1.24

0.53

1.0

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

423

1.18

0.53

1.6

1.5

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

351

3309

1.06

0.52

1.3

3.64

3.55

ug/l

0.08

322

2977

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

152

1.32

0.52

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

123

1112

1.11

0.51

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

342

1.20

0.51

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

342

1.20

0.51

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

361

1.19

0.50

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

270

1.22

0.49

1.3

1.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

124

1127

1.10

0.47

1.0

1.1

0.76

1.75

u/ml

1.27

328

(3020650) Glucose [Presence] in Urine

428

1.17

0.47

1.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

116

1052

1.10

0.47

2.5

2.8

904.80

717.45

e6/l

2.92

110

1026

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.46

0.46

1.1

1.0

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

128

1167

1.10

0.46

1.1

1.3

1.96

1.94

mmol/l

0.07

121

1099

(3014133) Dog dander IgE Ab [Units/volume] in Serum

287

2702

1.06

0.46

1.1

5.66

4.23

u/ml

0.33

137

1271

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.38

0.45

1.5

1.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

552

1.14

0.45

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

103

1.36

0.45

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.40

0.45

11.1

9.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

104

941

1.11

0.44

1.3

123.20

173.21

pmol/l

2.90

104

941

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

183

1.26

0.44

1.4

1.3

62.75

56.90

0.25

(3042631) Mycobacterium sp identified in Specimen

160

1478

1.08

0.44

2.2

2.7

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

139

1.30

0.43

1.3

1.4

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

175

1.26

0.43

1.0

0.01

0.40

u/ml

1.16

129

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

185

0.76

0.43

1.1

1.3

—

(3020618) Glucose [Moles/volume] in Synovial fluid

1.52

0.41

1.0

8.16

4.93

mmol/l

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.41

0.0

1.1

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.41

0.0

3.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.41

0.0

1.1

—

1575.00

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

342

1.17

0.40

1.2

1.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.47

0.40

1.0

1.7

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

141

1.28

0.40

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

150

1.27

0.40

1.9

3.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

115

1252

0.92

0.39

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.43

0.39

1.0

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

142

1.27

0.38

1.1

2.33

1.68

umol/24h

0.93

142

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

251

2375

1.06

0.38

2.6

3.5

699.65

616.81

u/ml

0.09

231

2178

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.32

0.37

1.6

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

364

1.15

0.37

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

246

0.81

0.36

1.2

2.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

296

3107

0.95

0.36

1.7

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.33

0.35

1.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

190

1.21

0.34

2.3

2.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.36

0.34

1.8

2.6

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

163

1.23

0.34

1.1

1.0

0.02

0.56

u/ml

1.65

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.33

0.33

1.8

2.8

—

(3020393) Adenovirus Ag [Presence] in Stool

118

1.27

0.33

1.1

—

(3003157) Bacteria [#/volume] in Mother's milk

1.30

0.33

4.0

7.8

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

146

1.23

0.32

1.4

1.3

0.40

1.72

mmol/l

1.72

(3034092) Cytoplasmic Ig cells/100 cells in Blood

165

0.79

0.32

3.3

6.1

—

(3046861) Legionella sp Ag [Presence] in Urine

1.30

0.30

1.3

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

100

928

1.08

0.29

1.2

1.3

—

(3009871) Measles virus Ab [Titer] in Serum

640

1.09

0.29

1.7

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

213

1.17

0.29

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

190

1806

1.05

0.28

1.7

1.6

—

(3022475) Manganese [Moles/volume] in Blood

118

0.76

0.27

1.1

1.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

205

1.17

0.27

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

1.19

0.26

1.1

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

141

1.21

0.26

1.8

1.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

123

1.22

0.25

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.71

0.24

4.8

4.7

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

765

0.93

0.23

1.3

1.2

78.00

65.66

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.76

0.22

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

181

1.16

0.22

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

544

1.08

0.22

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

153

1.18

0.22

1.0

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

111

1050

1.06

0.21

1.0

0.20

0.82

u/ml

1.06

222

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

0.00

0.21

0.0

2.1

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.21

0.0

1.9

—

14.75

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

201

1.14

0.21

5.8

6.8

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

199

1913

1.04

0.21

1.8

1.7

1760.00

1804.85

titre

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

(3007463) Buprenorphine [Presence] in Urine

1.24

0.20

6.6

7.3

—

(3042951) Complement C1q Ab [Units/volume] in Serum

1.25

0.20

1.1

—

19.91

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

501

1.08

0.19

3.5

4.1

—

(40758358) Immune stain study

1.19

0.18

1.0

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

186

1.13

0.16

1.4

1.2

1.64

1.82

mmol/l

0.17

107

(40761995) Spermatozoa Progressive [#/volume] in Semen

246

0.89

0.16

3.0

2.9

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

225

1.11

0.16

2.2

2.8

138.85

21.32

mg/l

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

283

1.10

0.15

1.9

1.3

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

245

0.90

0.15

5.9

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

293

1.09

0.15

1.2

1.4

1.16

2.91

1.59

249

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.20

0.15

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.11

0.15

1.2

2.0

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

352

1.08

0.14

1.3

1.4

65.76

61.36

0.35

292

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

181

0.88

0.14

2.7

1.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

949

1.04

0.14

1.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

315

0.92

0.13

1.7

2.1

2.24

3.15

ug/l

0.43

187

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

190

0.89

0.13

1.1

1.0

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

804

0.96

0.12

2.7

2.8

44.73

41.28

0.98

448

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

356

1.07

0.11

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

444

1.06

0.11

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

312

0.93

0.11

1.0

1.3

—

(3019174) dRVVT (LA screen)

163

1.10

0.10

1.2

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.15

0.10

1.1

0.07

3.88

u/ml

0.74

(3035933) Granulocytes/100 leukocytes in Blood

484

0.95

0.10

1.3

1.8

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.09

0.09

1.0

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

747

0.96

0.09

1.0

228.51

367.28

ng/l

2.00

543

(3013762) Body weight Measured

1.11

0.09

1.0

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

136

1.10

0.08

1.1

1.3

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.83

0.08

1.0

1.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.09

0.08

1.0

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.14

0.08

1.0

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.14

0.08

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

519

1.04

0.08

1.1

—

(21494434) Karyotype in Bone marrow

954

1.03

0.07

1.1

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

166

1.08

0.07

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

362

1.05

0.07

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

303

3070

0.99

0.07

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

303

3070

0.99

0.07

1.1

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

1.04

0.07

1.7

1.8

170.25

181.16

ng/l

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

752

0.97

0.07

1.0

32.39

40.86

ng/l

1.58

535

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

104

1065

0.98

0.07

1.3

1.45

1.58

g/l

4.15

104

1065

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.05

0.07

2.7

1.9

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.84

0.06

1.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

433

1.04

0.06

1.4

1.9

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

533

1.03

0.06

1.1

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

749

0.97

0.06

1.0

919.67

745.89

ng/l

2.34

525

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

360

3634

0.99

0.05

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

544

1.03

0.05

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

100

1.10

0.05

1.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

232

0.95

0.05

1.2

1.4

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

737

0.98

0.05

1.5

1.6

3111280.17

1891523.92

iu/ml

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

169

1.07

0.05

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1008

0.98

0.04

5.3

6.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

142

1439

0.99

0.04

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

239

1.05

0.04

1.0

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

271

0.96

0.04

1.7

—

(21494814) CD8 cells/100 lymphocytes in Specimen

553

0.98

0.03

1.4

2.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

579

1.02

0.02

1.1

349.40

457.28

ng/l

—

119

(3032352) Blasts [#/volume] in Cerebral spinal fluid

128

0.94

0.02

1.7

2.6

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

148

0.95

0.02

1.2

1.4

6.80

10.41

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

342

1.02

0.01

1.3

1.2

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

463

1.02

0.01

1.3

1.2

14.89

20.83

—

(1761868) Lipid panel - Serum or Plasma

5844

58424

1.00

0.00

3.0

2.5

—

(40765096) Chromosome analysis panel by Banding

336

0.98

0.00

1.2

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

164

0.98

0.00

1.3

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.04

0.00

1.2

1.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.04

0.00

1.0

1.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

257

1.01

0.00

1.5

4.8

54.15

61.15

u/l

0.17

250

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

472

1.00

0.00

2.4

1.9

10770.00

8551.03

u/ml

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

165

1.03

0.00

3.5

2.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

267

2672

1.00

0.00

1.1

2.21

2.84

u/ml

0.79

1429

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

459

1.00

0.00

3.2

3.3

—

(3010937) Rubella virus Ab [Presence] in Serum

128

1.02

0.00

1.1

—

(3025130) Human papilloma virus identified in Specimen

308

3081

1.00

0.00

1.6

1.7

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

312

0.99

0.00

1.1

1.2

—

(3010503) CD19 cells [#/volume] in Blood

865

1.01

0.00

2.4

2.7

0.30

0.36

e9/l

0.17

845

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.0

1.6

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.1

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.2

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

-0.00

0.0

1.6

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.93

-0.00

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.95

-0.00

1.7

1.5

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.01

-0.00

1.1

—

(3023006) Beef IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.31

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

-0.00

0.0

1.0

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_OBESITYNAS and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_OBESITYNAS	2.219 [1.99, 2.48]	< 0.001
Birth year	0.999 [0.99, 1.01]	0.862

During the follow-up period (1.1.1998 — 31.12.2019), 3644 out of 40743 females with E4_OBESITYNAS died.

Males

Parameter	HR [95% CI]	p-value
E4_OBESITYNAS	2.399 [2.16, 2.66]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.032

During the follow-up period (1.1.1998 — 31.12.2019), 4004 out of 24666 males with E4_OBESITYNAS died.

Mortality risk

Mortality risk for people of age

years, who have E4_OBESITYNAS.

N-year risk	Females	Males
1	0.233%	0.497%
5	1.528%	2.936%
10	3.373%	7.02%
15	6.864%	13.363%
20	11.998%	22.102%

Relationships between endpoints

↥

Index endpoint: E4_OBESITYNAS – Obesity, other/unspecified

GWS hits: 42

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Obesity, other/unspecified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints